Document:

exv10w2

Exhibit 10.2

*** Text Omitted and Filed Separately

Confidential Treatment Requested

Under 17 C.F.R. §§ 200.80(b)(4)

and 203.406

Alliance Agreement

by and between

Uhde Corporation of America

and

Myriant Technologies LLC

*** Confidential Treatment Requested

 

 

TABLE OF CONTENTS

	 	 	 	 	 

	Alliance Agreement
	 	 	1	 
	Recitals
	 	 	2	 
	A. Alliance Structure
	 	 	2	 
	A.1 General Structure and Purposes of the Alliance
	 	 	2	 
	A.1.1 Exclusive Alliance Arrangements
	 	 	2	 
	A.2 Conduct and Governance of the Alliance
	 	 	3	 
	A.3 Costs
	 	 	4	 
	A.4 Exchange of Information
	 	 	4	 
	B Joint Research and Development and Intellectual Property
	 	 	4	 
	B.1 Rights to the Uhde Process
	 	 	4	 
	B.2 Intellectual Property Ownership
	 	 	4	 
	B.2.1 Myriant Rights
	 	 	4	 
	B.2.2 UCA Rights
	 	 	4	 
	B.3 Improvements and Working Results
	 	 	5	 
	B.3.1. Myriant Improvements
	 	 	5	 
	B.3.2 Uhde Improvements
	 	 	5	 
	B.3.3 Joint Working Results
	 	 	5	 
	B.4 Use and License Rights
	 	 	6	 
	B.4.1 Myriant Grant of Use Rights to UCA
	 	 	6	 
	B.4.2 UCA Grant of Use Rights To Myriant
	 	 	6	 
	B.4.3 UCA Grant of Uhde Process Plant Licenses
	 	 	7	 
	B.4.4 Uhde Process License Fee
	 	 	7	 
	B.4.5 Myriant Grant of Sublicense Rights
	 	 	7	 

*** Confidential Treatment Requested

 

 

	 	 	 	 	 

	B.4.6 UCA Grant of Sublicense Rights
	 	 	7	 
	B.5 Application of Intellectual Property Rights and Maintenance
of Intellectual Property Rights
	 	 	8	 
	B.5.1. Application for Intellectual Property Rights
	 	 	8	 
	B.5.2. Costs
	 	 	8	 
	B.5.3. Notice Rights
	 	 	8	 
	B.5.4. Joint Filing of Application
	 	 	8	 
	B.5.5. Separate Application of Either Party
	 	 	9	 
	B.5.6 Maintenance of IP Rights
	 	 	9	 
	B.5.7 Laws on Employees’ Invention
	 	 	9	 
	B.5.8 Claiming of Employees’ Inventions
	 	 	9	 
	B.6. Infringement of Intellectual Property Rights
	 	 	10	 
	B.6.1 Information about Possible Infringements
	 	 	10	 
	B.6.2 Defense
	 	 	10	 
	B.6.3 Information about Charges and Mutual Support
	 	 	10	 
	B.6.4 Charges by other Party
	 	 	10	 
	B.7 Termination of the Agreement
	 	 	11	 
	B.7.1 Ownership
	 	 	11	 
	B.7.2 Continuing Rights to Working Results upon Termination
	 	 	11	 
	B.7.3 Licensing of Joint Working Results
	 	 	11	 
	B.7.4 Licensing of Separate IP Rights
	 	 	11	 
	B.7.5 Maintenance of IP Rights
	 	 	11	 
	B.7.6 Sale of IP Rights
	 	 	12	 
	B.8 Compensation
	 	 	12	 

*** Confidential Treatment Requested

 

 

	 	 	 	 	 

	C. Project Marketing
	 	 	12	 
	C.1 Activities
	 	 	12	 
	C.2 Business Development Projects
	 	 	12	 
	C.3 Proposal Development
	 	 	13	 
	C.4 Proposal Costs
	 	 	15	 
	C.5 [...***...]
	 	 	15	 
	C.6 Process and Performance Guarantees
	 	 	15	 
	D. Miscellaneous
	 	 	15	 
	D.1 Effective Date
	 	 	15	 
	D.2 Representation
	 	 	15	 
	D.3 Confidentiality Agreement
	 	 	16	 
	D.4 Term
	 	 	16	 
	D.4.1 Termination of Agreement
	 	 	16	 
	D.4.2 Termination with Immediate Effect
	 	 	16	 
	D.5 Cooperation in the Light of Antitrust Laws
	 	 	17	 
	D.6 Waiver of Terms
	 	 	17	 
	D.7 Entire Agreement, Execution Costs, No Assignment
	 	 	17	 
	D.8 Liability/Indemnity
	 	 	17	 
	D.9 Governing Law/Mediation/Arbitration
	 	 	18	 
	D.10 Amendments
	 	 	19	 
	D.11 Severability
	 	 	19	 
	D.12 Force Majeure
	 	 	20	 
	D.13 Further Assurances
	 	 	20	 
	 
	Annex 1-Definitions
	 	 	21	 

*** Confidential Treatment Requested

 

 

	 	 	 	 	 

	Exhibit A — Uhde Process License Fee Structure
	 	 	24	 
	Exhibit B — Engineering and Plant Proposal Fees
	 	 	25	 
	Exhibit C — [...***...]
	 	 	26	 

*** Confidential Treatment Requested

 

 

Alliance Agreement

This Alliance Agreement (the “Agreement”) by and between Uhde Corporation of America, a
Delaware corporation, with its principal offices located at 1370 Washington Pike Bridgeville, PA
15017, USA (hereinafter referred to as “UCA”) and Myriant Technologies LLC, a Delaware
limited liability company, with its principal offices located at 1 Pinehill Drive, Batterymarch
Park II, Suite 301, Quincy, MA 02169 USA (hereinafter referred to as “Myriant”); each of
UCA and Myriant are singularly also referred to herein as “Party” and jointly as “Parties”
(certain capitalized terms shall have the meaning ascribed to them as set forth in Annex 1 attached
hereto and made a part hereof).

Recitals

WHEREAS, UCA is an internationally recognized engineering and procurement company active in the
field of chemical, refining, petrochemical and other industrial plants, has exclusive access to
different proprietary technologies and has extensive know-how and experience in the engineering and
construction of such technology related plants;

WHEREAS, Myriant is a science and technology company active in the development and
commercialization of next generation biorefineries for the production of bio-based chemicals and
fuels from renewable feedstocks, possesses the know-how to produce such fuels and chemicals, and is
developing a proprietary fermentation process for the production of Succinic Acid (herein referred
and hereinafter defined as the “Myriant Process”);

WHEREAS, UCA and Myriant intend to exclusively cooperate in their research and development efforts
(the “Joint R&D”) hereunder to jointly develop and optimize their respective Processes (as
defined herein) for the production of Succinic Acid in the “Pilot Plant” (as defined herein) and
the “Demonstration Plant” (as defined herein), and the Parties shall license their respective
Processes to each other on a royalty-free basis solely in furtherance of this objective;

WHEREAS, UCA and Myriant intend to exclusively cooperate in their business development efforts (the
“Project Marketing”) to market, jointly develop, bid and execute “Projects” (as defined
herein) for the design, engineering, and procurement of commercial scale Succinic Acid Plants in
the United States incorporating their respective Processes;

WHEREAS, Myriant intends to use UCA exclusively for engineering and as its procurement contractor
for commercial-scale Succinic Acid Plants in the United States incorporating their respective
Processes;

WHEREAS, Uhde GmbH, an “Affiliate” (as defined herein) of UCA, has the know-how to isolate organic
acids, and has developed separation technology for the isolation of Organic Acids, including
Succinic Acid (herein referred to and hereinafter defined as the “Uhde Process”);

WHEREAS, UCA has obtained from Uhde the full and exclusive rights to commercialize the Uhde Process
in the United States and intends to license it to

*** Confidential Treatment Requested

1

 

Myriant for use in (i) the Pilot Plant and Demonstration Plant hereunder on a royalty-free basis;
and (ii) any “Plants” for which UCA shall also be providing a “Process and Performance Guaranty” in
accordance with the license fees payable hereunder for such use; (iii) those limited exceptions in
which UCA will not be acting as the E&P contractor, on mutually acceptable terms and conditions to
be agreed upon by UCA and Myriant; and

WHEREAS, Uhde and Myriant are concurrently entering into a parallel agreement with similar terms
and conditions for all regions of the world outside of the United States.

Now, therefore, in consideration of the foregoing and for good and other valuable consideration,
the mutual receipt and sufficiency of which is hereby acknowledged. the Parties hereto agree to the
following, which shall govern their cooperation:

	A. ALLIANCE STRUCTURE
	 
	A.1 	 	General Structure and Purposes of the Alliance
	 
	 	 	a) The Alliance shall be based upon the Parties’ joint research and development efforts to
collaborate exclusively with each other to integrate and deploy the “Processes” (as
defined herein) in the Demonstration Plant, the Pilot Plant and future Plants during the
“Term” (as defined herein) hereof. The Parties envision that they shall first deploy the
Processes in the proposed Pilot Plant, which shall be operated by Myriant or its agents.
	 
	 	 	b) During the later stages of the Term, and subject to the conditions provided herein, the
Parties shall cooperate in “Project Marketing,” which shall include, without limitation,
the development of Projects and construction of Plants that Myriant or its Affiliates may
(i) own, lease, operate or manage, (ii) supply products to the end customer(s) and/or
(iii) have the contractual relationship for such supply of the Plant’s products to the end
customer(s) and in which UCA shall act as its exclusive engineering and procurement
contractor.
	 
	 	 	c) Myriant and UCA will each assign experienced personnel to the Alliance for the purpose
of advancing the purposes of the Alliance, including the Joint R&D and Project Marketing
as detailed herein. Myriant shall perform Project
	 
	 	 	Marketing with regard to the end customer(s) with reasonable technical assistance provided
by UCA and/or its Affiliates.
	 
	A.1.1 	 	Exclusive Alliance Arrangements
	 
	 	 	a) Except as otherwise provided in Item C.2.e, UCA or one of its Affiliates shall perform
its services as Myriant’s exclusive engineering and procurement contractor (“EP”)
for any Plants located in the United States during the Term hereof, provided,
however, that Myriant may, subject to the Item C.2.e, individually pursue Projects
only where (i) UCA has affirmatively elected and advised Myriant in writing of its
decision not to pursue jointly with Myriant a Project; or (ii) UCA is unable to proceed on
a Project because of its inability to

*** Confidential Treatment Requested

2

 

	 	 	provide Project process and performance guarantees acceptable to the particular Project
lender; further, provided, however, that Myriant shall only
proceed to use the Uhde Process for such Projects in accordance with Item B.4.3 hereof and
further, provided, however, that the provision of [...***...]. UCA, on the other hand,
shall not in any case during the Term hereof, pursue any Project without Myriant.
	 
	 	 	b)  Myriant and its Affiliates, subject to the exceptions provided herein, will not enter
into discussions or negotiations with, solicit a proposal from, or consider any
unsolicited proposal from any other EP contractors for Projects. UCA and its Affiliates,
subject to the exceptions provided herein, will not enter into discussions or negotiations
with, solicit a proposal from, or consider any unsolicited proposal from any other third
party for the realization of Projects; provided, however, that it is
expressly agreed between the Parties that UCA remains free to provide and to actively
market the Uhde Process and, within the restrictions of Item B.4.5, Myriant Intellectual
Property Rights to any third party for plants in the United States that are not intended
to produce Succinic Acid.

	A.2 	 	Conduct and Governance of the Alliance

	 	a)	 	The Parties will establish an Alliance steering committee with four (4) members with
equal representation by Myriant and UCA (the “Steering Committee”).
	 
	 	b)	 	The Steering Committee shall convene in person, by videoconference or telephonically
on no less than a quarterly basis, and on shorter notice if circumstances dictate, to
review the performance of the Alliance, address any issues or disputes and take such other
actions as may advance the purposes of the Alliance. The Steering Committee shall have
such other responsibilities as set forth herein and shall also review and recommend
specific Projects for bid to the Parties, decide whether or not to bid for a specific
Project, and decide on further research and development work in connection with the
Processes.
	 
	 	c)	 	The Parties will establish a project team (the “Project Team”), with equal
representation by Myriant and UCA, The Project Team’s basic functions shall be:

	 	i	 	development of the upstream and downstream Processes, including the
harmonization of the economics on both parties’ sides,
	 
	 	ii	 	selection of technologies to be used for future Plants,
	 
	 	iii	 	ensuring the scale up and continuous run of Pilot Plant,
	 
	 	iv	 	selection and design of Uhde Process for the Demonstration Plant,
	 
	 	v	 	oversight and coordination of engineering, construction, start-up and
operation of the Demonstration Plant, and

*** Confidential Treatment Requested

3

 

	 	vi	 	oversight and coordination of design, construction and start-up of new
Plants.

	A.3 	 	Costs
	 
	 	 	Except with respect to UCA’s Project Proposal preparation costs as provided in Item C.4,
each Party shall bear its respective fees, costs, and expenses for all of the activities
of the Alliance, including for Joint R&D and Project Marketing. The Parties shall not
share any additional expense or cost in connection with efforts (e.g., for joint
developments, employment of external third parties etc.), unless specifically agreed to in
writing in advance by duly authorized representatives of the Parties.
	 
	A.4 	 	Exchange of Information
	 
	 	 	Each Party shall promptly inform and update each other of its progress in the research and
development of its respective Processes, unless rights of third parties prevent such
disclosure of information. Further, the Parties shall collaborate with each other and
share their respective expertise to solve any problems or questions that may arise in the
course of the joint research and development work.

	B JOINT RESEARCH AND DEVELOPMENT AND INTELLECTUAL PROPERTY
	 
	B.1 	 	Rights to the Uhde Process
	 
	 	 	UCA represents and warrants that it has the full authority and
capability to execute and perform this Agreement and that such
execution and performance will not violate any restriction obtained
in any law or regulation, or in any agreement between UCA and Uhde
or any third party. Uhde further represents and warrants that it
has licensed to UCA all right, title and interest in and to the
Uhde Process for exclusive use in the United States and that UCA,
as licensee, has the full right to sublicense rights to the Uhde
Process and any Uhde Improvements to Myriant solely for use in
connection with Succinic Acid for the purposes of this Agreement.
	 
	B.2 	 	Intellectual Property Ownership
	 
	B.2.1 	 	Myriant Rights
	 
	 	 	Myriant owns or is the licensee of all right, title and interest in
and to any pre-existing Intellectual Property Rights to the Myriant
Process, including any Prior IP Record. As between the Parties,
Myriant has the exclusive right, at its sole discretion and
expense, to apply for, register, maintain and enforce Patents and
other Intellectual Property Rights as it deems appropriate with
respect to any of the pre-existing Intellectual Property Rights it
has to the Myriant Process.
	 
	B.2.2 	 	UCA Rights

*** Confidential Treatment Requested

4

 

	 	 	UCA is the sole and exclusive licensee in the United States and
possesses all right, title and interest in and to any pre-existing
Intellectual Property Rights to the Uhde Process, including any
Prior IP Record. As between the Parties, UCA has the exclusive
right, at its sole discretion and expense, to apply for, register,
maintain and enforce Patents and other Intellectual Property Rights
in the United States as it deems appropriate with respect to any of
the pre-existing Intellectual Property Rights it has to the Uhde
Process. UCA shall provide to Myriant a copy of the Uhde Process
license from Uhde to UCA and any amendments thereto.
	 
	B.3 	 	Improvements and Working Results
	 
	B.3.1. 	 	Myriant Improvements
	 
	 	 	Myriant Improvements, as such Improvements are described herein
and in any Prior IP Record, shall be the sole property of Myriant,
and all rights, including Intellectual Property Rights, shall vest
solely in Myriant. Accordingly, Myriant hereby licenses to UCA any
and all right, title and interest in and to any Myriant
Improvements pursuant to this Item B.3.1 to the extent necessary
for UCA to complete any of the tasks contemplated herein for the
Term of this Agreement. UCA agrees to execute documents, render
such reasonable assistance, and take such other reasonable action
at Myriant’s expense as Myriant may reasonably request to apply
for, registered, perfect, confirm and protect any Myriant
Improvements it conceives under this Item B.3.1.
	 
	B.3.2 	 	Uhde Improvements
	 
	 	 	Uhde Improvements, as such Improvements are described herein and
in any Prior IP Record, shall be the sole property of UCA, and all
rights, including Intellectual Property Rights, shall vest solely
in UCA. Accordingly, UCA hereby licenses to Myriant any and all
right, title and interest in and to any Uhde Improvements pursuant
to this Item B.3.2 to the extent necessary for Myriant to complete
any of the tasks contemplated herein for the Term of this
Agreement. Myriant agrees to execute documents, render such
reasonable assistance, and take such other reasonable action at
UCA’s expense as UCA may reasonably request to apply for,
registered, perfect, confirm and protect any Working Results it
conceives under this Item B.3.2.
	 
	B.3.3 	 	Joint Working Results
	 
	 	 	Joint Working Results shall be the joint property of both Parties,
and the rights for such Working Results shall vest jointly in both
Parties as provided herein (as defined hereinafter in Annex 1, the
“Joint Working Results”). Each Party agrees to grant, and hereby
does grant, usage rights to the other Party for any Joint Working
Results for any purposes contemplated under this Agreement.
Further, each Party shall not impair the other Party’s right to use
the Joint Working Results for any such purposes.
	 
	 	 	Notwithstanding the foregoing, the Steering Committee of the
Parties shall consider [...***...], including the

*** Confidential Treatment Requested

5

 

	 	 	[...***...] between the Parties,
when determining [...***...]. [...***...]
	 
	 	 	Any allocation of license fees by the Steering Committee shall be distributed between the
Parties in proportion to each Party’s contribution and in only one of the following three
proportions:

	 	a)	 	[...***...]% to the Party judged by the
Steering Committee to have made the primary contribution to the Joint
Working Results (the “Primary Developer”) and [...***...]% to
the Party judged by the Steering Committee to have made a lesser
contribution (the “Secondary Developer”);
	 
	 	b)	 	[...***...]% to each Party in the event that
both Parties are judged by the Steering Committee to have made equal
contributions or in the event that the Steering Committee cannot
determine within a reasonable time the respective contributions of the
Parties, or
	 
	 	c)	 	[...***...]% to the Primary Developer in the
event that the Steering Committee determines (1) that the Primary
Developer made an overwhelming contribution to the Joint Working
Results and/or (2) that the contribution consists solely of an Uhde
Improvement or a Myriant Improvement.

	 	 	The Steering Committee shall also consider the respective efforts that the Parties take in
the commercialization of the Joint Working Results when making any adjustments to the
foregoing allocation of the license fees. The Steering Committee shall also determine
whether to make[...***...].
	 
	 	 	In the event of a dispute in which one party claims to have made 100% of the contribution
and the other party claims to have made more than a de minimis contribution to the Joint
Working Results, the Parties shall refer the matter to the intellectual property rights
mediator as provided for in Item D.9.

	B.4 	 	Use and License Rights
	 
	B.4.1 	 	Myriant Grant of Use Rights to UCA
	 
	 	 	Subject to any existing third party licensing restrictions, Myriant
hereby grants to UCA a non-exclusive, royalty-free right and license
to use within the United States Myriant’s pre-existing Intellectual
Property Rights, the Myriant Process, any Myriant Improvement, and
any Joint Working Results during the Term solely for the Project’s
purposes.
	 
	B.4.2 	 	UCA Grant of Use Rights To Myriant

*** Confidential Treatment Requested

6

 

	 	 	Subject to any existing third party licensing restrictions, UCA
hereby grants to Myriant a non-exclusive, royalty-free right and
license to use within the United States UCA’s pre-existing
Intellectual Property Rights, the Uhde Process, any Uhde
Improvement, and any Joint Working Results during the Term, solely
for the Project’s purposes
	 
	B.4.3 	 	UCA Grant of Uhde Process Plant Licenses
	 
	 	 	UCA hereby grants to Myriant (i) an exclusive, royalty-free right
and license to use the Uhde Process, any Uhde Improvement and any
Joint Working Result for use in the Pilot Plant and the
Demonstration Plant, (ii) an exclusive right and license to use the
Uhde Process and any Uhde Improvement for any Plants in the United
States where UCA is providing a “Process and Performance Guaranty”
in accordance with Item C.6, subject to the license fee payable to
UCA in accordance with Item B.4.4, and (iii) [...***...].
	 
	B.4.4 	 	Uhde Process License Fee
	 
	 	 	For the right to use the Uhde Process and any Uhde Improvement in accordance with Item
B.4.3(ii) above, Myriant shall pay to UCA per Project in accordance with the license fee
structure described on Exhibit A attached hereto and made a part hereof. The license fee
shall be subject to adjustment in accordance with Item B.3 hereof.
	 
	B.4.5 	 	Myriant Grant of Sublicense Rights
	 
	 	 	Myriant hereby grants UCA a perpetual, non-exclusive right and
license within the United States, including the right to grant and
authorize sublicenses, under Myriant Intellectual Property Rights
other than to its Joint Working Results, including rights in and to
the Myriant Process and any Myriant Improvement; provided that UCA
obtains prior written approval from Myriant, such approval which may
be granted at Myriant’s sole discretion, and provided further that
for each particular sublicense, the Steering Committee shall agree
on the principal terms and conditions of any such sublicense,
including the terms and conditions and the royalty rate. With
respect to Joint Working Results, [...***...].
	 
	B.4.6 	 	UCA Grant of Sublicense Rights
	 
	 	 	UCA hereby grants Myriant a perpetual, non-exclusive right and
license within the United States, including the right to grant and
authorize sublicenses, under Uhde Intellectual Property Rights,
including rights in and to the Uhde Process and any Uhde
Improvement, provided that Myriant obtains prior written approval
from UCA for any sublicenses (which shall not be

*** Confidential Treatment Requested

7

 

	 	 	unreasonably withheld or delayed where where UCA is not acting as the E&P contractor in
accordance with Item A.1.1(i) and (ii)), and further provided that for each particular
sublicense, the Steering Committee shall agree on the principal terms and conditions of
each such sublicense, including the term and the royalty rate. In the case where UCA is
not acting as the E&P contractor in accordance with Item A.1.1(i) and (ii), if the Parties
are unable to agree on such terms and conditions, then the matter may be referred to the
intellectual rights mediator for resolution as provided for in Item D.9. With respect to
Joint Working Results, [...***...].
	 
	B.5 	 	Application of Intellectual Property Rights and Maintenance of Intellectual Property Rights
	 
	B.5.1 	 	Application for Intellectual Property Rights
	 
	 	 	In the case that any development or a part of it which is entered
into the project by either Party, and which this Party developed
without reference to information of the other Party, can be
protected by Intellectual Property Rights, either Party shall
promptly enter such application to the respective authorities.
Either Party shall refrain from applying for any Intellectual
Property Rights for such development or information or parts of such
development or information which is provided by the other Party,
unless agreed to by both Parties and filed jointly under provisions
of Item B.5.4.
	 
	B.5.2 	 	Costs
	 
	 	 	The costs for the application, receipt and maintenance of such
Intellectual Property Rights shall be borne by that Party that
applies for such rights.
	 
	B.5.3 	 	Notice Rights
	 
	 	 	The Party applying for any Intellectual Property Rights (the
“Applying Party”) shall inform the other Party (the “Non-Applying
Party”) immediately after applying, filing or registration of such
rights so as to give the other Party the opportunity to have its
business interests addressed by having the Applying Party add any
issues to the application that the Non-Applying Party may request to
have its business interests sufficiently covered. An Applying Party
shall also notify the Non-Applying Party if it intends to disregard,
diminish or otherwise restrict the scope of any claims to
Intellectual Property Rights in an application, filing or
registration process for any Intellectual Property Rights. The
Applying Party shall notify the Non-Applying Party for any such
action in the course of a grant, appeal or complaint process, if the
interests of the other Non-Applying Party may be, or are affected
by, such action.
	 
	B.5.4 	 	Joint Filing of Application
	 
	 	 	In the case of filing for Intellectual Property Rights according to
Item B.5.1 above the Parties shall jointly file the application for
having their Intellectual Property Rights registered. The costs for
such joint application, filing and/or registration shall be borne by
both Parties jointly and equally. With respect to

*** Confidential Treatment Requested

8

 

	 	 	any such filing, the Parties shall mutually decide on the territorial/regional extent of
their application. If either Party is explicitly not interested in applying for
Intellectual Property Rights in any country or region, the other Party shall be free to
apply for Intellectual Property Rights in that country/region without the participation of
the Party forgoing the opportunity to apply for such Rights. In such a case and for such
countries/regions, the Applying Party shall be the sole possessor of the Intellectual
Property Rights it applies for and shall bear all additional costs arising out of any such
applications. The Non-Applying Party shall nevertheless have a non-exclusive right to use
such Intellectual Property Rights.
	 
	B.5.5 	 	Separate Application of Either Party
	 
	 	 	If a Party is not interested in applying for Intellectual Property
Rights, it shall give the other Party sufficient time to apply for
and obtain such Intellectual Property Rights at any place the
Applying Party contemplates making a filing related to its
Intellectual Property Rights. Upon receipt of such notice, the
Applying Party shall have the right, at its own cost, to assume the
prosecution and maintenance with respect to such Intellectual
Property Right, as applicable, and the Non-Applying Party shall
assign all of its right, title and interest in and to such
Intellectual Property Right, or claim thereof, as applicable, to the
Applying Party. The Applying Party shall bear all costs and
obligations for any separate applications that it may elect to make
pursuant to this Item B.5.5.
	 
	B.5.6 	 	Maintenance of IP Rights
	 
	 	 	If a Party is not interested in maintaining an Intellectual Property
Right that it possesses, it shall give the other Party sufficient
time to analyze and consider whether it wishes to have the
Intellectual Property Right assigned or otherwise transferred to it
so that it may maintain the Intellectual Property Right. In the
event that the other Party decides to maintain such an Intellectual
Property Right, the Party in possession of such Intellectual
Property Right shall transfer it to the other Party.
	 
	B.5.7 	 	Laws on Employees’ Invention
	 
	 	 	The Parties shall claim inventions of their employees conceived in
the course of the collaboration contemplated by this Agreement
according to the national laws applicable to employees’ invention as
defined in Item D.9 hereunder, unless both Parties declare that they
do not have any interest in the invention.
	 
	B.5.8 	 	Claiming of Employees’ Inventions
	 
	 	 	Either Party shall arrange to obtain all rights, title and interest
in and to any inventions made by its own employees on its own. The
respective Party shall, however, coordinate with the other Party, if
such invention falls under the provisions of Items B.3.1, B.3.2, or
B.3.3. In the case of Working Results, the Party whose employees did
not contribute any inventions shall compensate the other Party for
making use of inventions made by the other Party’s

*** Confidential Treatment Requested

9

 

	 	 	employees according to the applicable national laws governing rights with respect to
employees’ inventions.
	 
	B.6 	 	Infringement of Intellectual Property Rights
	 
	B.6.1 	 	Information about Possible Infringements
	 
	 	 	The Parties shall inform each other without undue delay about any
suspected infringement of Intellectual Property Rights that may be
subject to or in connection with anything provided for under this
Agreement.
	 
	B.6.2 	 	Defense
	 
	 	 	The owner or licensor of the Intellectual Property Right that a
third party allegedly infringes shall defend its Intellectual
Property Right against such third party infringement. The Parties
shall coordinate their proceedings in such matters.
	 
	 	 	In the case that legal proceedings are taken against it, the Party
defending itself shall bear all costs related to its defense. The
costs incurred by a Party joining as a third-party defendant to such
a proceeding shall be borne by the Party thus joining.
	 
	B.6.3 	 	Information about Charges and Mutual Support
	 
	 	 	In the event a Party is alleged to have breached an Intellectual Property Right that is
related to or based on this Agreement, the allegedly infringing Party shall immediately
inform the other Party thereof. The other Party shall be entitled to join any legal
proceedings in the defense of such claims by third parties. The Party not addressed by
such claim shall be obliged to reasonably cooperate with the other Party.
	 
	B.6.4 	 	Charges by other Party
	 
	 	 	If (i) either Party, or its Affiliates, make or file a claim against the other Party for a
breach of Intellectual Property Rights that are subject to or arise in connection with
this Agreement, or (ii) a Party, or its Affiliates, support a third party in making a
claim for breach of Intellectual Property Rights, the other Party may terminate this
Agreement with immediate effect.
	 
	 	 	Upon effectiveness of the termination under this Item the Parties lose the right to use
the Intellectual Property Rights of the other Party as well as the Working Results of the
other Party. The terminating Party has to return to the other Party all information, such
as but not limited to documents, data, specimen etc. referring to the said Intellectual
Property Rights and for those Working Results which are the sole property of the other
Party, as far and if the terminating Party has received any of these from the other Party.
	 
	 	 	The Joint Working Results shall be dealt with according to Item B.7.3 below.

*** Confidential Treatment Requested

10

 

	B.7 	 	Termination of the Agreement
	 
	B.7.1 	 	Ownership
	 
	 	 	Upon effectiveness of termination of this Agreement, each Party shall remain owner of its
pre-existing Intellectual Property Rights, including any Prior IP Record, as provided for
in Items B.2.1 and B.2.2.
	 
	B.7.2 	 	Continuing Rights to Joint Working Results upon Termination
	 
	 	 	In the event of the election by both Parties to mutually terminate this Agreement prior to
the expiration of the Term, the Steering Committee shall meet to [...***...]. The
Steering Committee shall consider all relevant factors [...***...]. In the event that the
Steering Committee is unable to reach a determination of the Parties’ respective rights,
the Parties may refer the issue to the intellectual property mediator for resolution
pursuant to the mechanism provided for in Item D.9. In the event of a termination of this
Agreement arising out of a material breach by one of the Parties hereto, [...***...]. If
the Parties dispute the existence of a material breach, the Parties shall refer the matter
to arbitration as provided for in Item D.9.
	 
	B.7.3 	 	Licensing of Joint Working Results
	 
	 	 	In the event that this Agreement is terminated for any reason other
than a material breach, [...***...]; provided, however, that for
each particular sublicense, the Steering Committee shall
[...***...]. If the Parties are unable to agree on such terms and
conditions, then the matter may be referred to the intellectual
rights mediator for resolution as provided for in Item D.9.
	 
	B.7.4 	 	Licensing of Separate IP Rights
	 
	 	 	The Steering Committee shall negotiate and agree on reasonable
license fees and other terms and conditions for those Intellectual
Property Rights that are the sole property of either Party and to
which the other Party requires access to continue its research and
marketing activities.
	 
	B.7.5 	 	Maintenance of IP Rights
	 
	 	 	Upon effectiveness of the termination, neither Party shall be
obliged to maintain its patents or patent applications, irrespective
of these being joint or own patents or patent applications.
	 
	B.7.6 	 	Sale of IP Rights
	 
	 	 	If either Party decides to sell any of its Intellectual Property Rights, the other Party
shall have a pre-emptive right to buy this Intellectual Property Right from that Party at
a reasonable price to be negotiated between the Parties in good faith. The other Party may
consider such pre-emptive right for at least [...***...] upon receipt of an offer before
losing its right of decision on the offer. Any times of negotiation between the Parties
shall toll this time limit.

*** Confidential Treatment Requested

11

 

	B.8 	 	Compensation
	 
	 	 	Neither Party shall receive from the other Party compensation for
cooperating in the tasks contemplated by this Agreement. License fees
or any other forms of payment provided for separately under this
Agreement shall not be covered by this provision.

	 	 	C. PROJECT MARKETING
	 
	C.1 	 	Activities

	 	a)	 	Upon the commencement of first commercial production of Succinic Acid from any Plant
constructed hereunder, or at such earlier time as determined by the Steering Committee,
the Steering Committee will assume the oversight and coordination of proposal development
and Project marketing activities for the Alliance (herein “Project Marketing”).
The marketing activities shall include, without limitation, the following:

	 	(i)	 	determination as to which Projects it should market the Processes and to
whom it should do so; and
	 
	 	(ii)	 	[...***...];

	 	b)	 	The Parties will agree on forms of contract with mutually acceptable terms and
conditions for the provision of EP services. Furthermore, prior to start of engineering
the Demonstration Plant, the Parties will agree on a structure for pricing of such EP and
services that will induce both Parties to execute the Project in the most cost-effective
manner.
	 
	 	c)	 	The Parties shall work together in good faith to explore all related areas of
potential synergy that may enhance the ability of the Parties to win bids for and execute
Projects.

	C.2 	 	Business Development Projects

	 	a)	 	The Parties shall [...***...] on the development of Projects and [...***...]
with necessary sales and business development support, including, without limitation,
[...***...] with investor(s) for Projects, Plants, process case analysis,
budgetary and/or firm proposals and, to the extent required, any Intellectual Property
Rights necessary for the preparation of any Project proposal.
	 
	 	b)	 	The Parties [...***...] related to Projects
and Plants [...***...].
	 
	 	c)	 	The Parties shall convene on a regular monthly basis (or other frequency as mutually
agreed to by the Parties) in person, by videoconference or telephonically to review the
new business opportunities, prioritize such

*** Confidential Treatment Requested

12

 

	 	 	opportunities, inform each other about the current status of potential or existing Projects
and other new Project opportunities that have come to the knowledge of a Party, and to
develop strategies for jointly developing and acquiring such targeted opportunities.

	d)	 	If either Party has identified a prospective Project,
[...***...] .  [...***...] A decision to pursue a Project [...***...].
	 
	e)	 	[...***...]
	 
	f)	 	UCA shall offer and perform services to Myriant based on United States Dollars.
However, should UCA have parts of its services performed are based on Euro, to enable both
Parties to take advantage of fluctuating rates of exchange or to avoid their exposure
during the validity period of any proposal, UCA shall fix the rate of exchange for the
calculation of the respective Euro portion at the rate valid as of the date of the
proposal. Should there be an increase or decrease of the exchange rate at the date of
effectiveness of a contract based on such proposal, the USD-Price shall be fixed in the
contract by calculating this price according to the new exchange rate quoted by the
European Central Bank as official rate of exchange valid at the date of such
effectiveness.
	 
	g)	 	If an identified Project requires the Parties to enter into a joint venture with any
third party due to national or other legal restrictions, the Parties shall discuss and
agree on the appropriate structure on a case by case basis.
	 
	C.3 	 	Proposal Development
	 
	 	 	The Parties recognize that during the Plant Proposal development process, Myriant may
require budgetary cost and performance information for its own evaluation of the
development of budgetary proposals for Myriant’s own investment purposes, an end customer
or a third party investor or lender for a Plant, and/or for screening of process and/or
supply concepts. UCA agrees to provide at its own cost the necessary sales and business
development support for such budgetary estimates as outlined below. Myriant will provide a
functional specification for each opportunity, which will include, at a minimum: product
requirements, feed information, utility availability, economic evaluation criteria, and
preliminary site information. UCA shall provide the following deliverables for each
budgetary proposal opportunity:

*** Confidential Treatment Requested

13

 

	 	•	 	Preliminary Process Flow Diagram (PFD) with its associated material balance;
	 
	 	•	 	Consumption/utility estimates; and
	 
	 	•	 	Budgetary cost estimates (+/-30%).

	 	 	If Myriant asks for a firm proposal by UCA, or if the Parties agree to jointly develop a
Project proposal for an end customer or investor or lender, they will agree on the scope
of work, the design basis of the Project, and the process concept as well as the
time-schedule for the proposal deliverables. The UCA project scope of work will typically
be an engineering/procurement approach (EP). In case of an EP approach, if required for
financing purposes, UCA is willing to act as a subcontractor to the construction or prime
contractor.
	 
	 	 	Myriant will provide a detailed specification for each Project proposal. This
specification will include, at a minimum:

	 	•	 	a process functional definition —including product requirements, feed
information, utility availability, emission limitations, and economic evaluation
criteria;
	 
	 	•	 	a technical specification — including equipment design criteria, instrumentation
requirements, and applicable codes and standards; and
	 
	 	•	 	an execution specification — including scope of work matrix, communication
requirements, schedule requirements, and site information.

	 	 	The schedule for the UCA deliverables shall be agreed on by and between the Parties for
each Project proposal. The following UCA deliverables are typical and depend on UCA
Scope:

	 	a)	 	Technical Deliverables:

	 	•	 	Process flow diagram (PFD) with process description;
	 
	 	•	 	Heat and material balance;
	 
	 	•	 	Preliminary utility consumption (amounts and requirements); and
	 
	 	•	 	Preliminary time schedule.

	 	b)	 	Commercial Deliverables:

	 	•	 	Cost estimate (for UCA scope only):

	 	•	 	Engineering services;
	 
	 	•	 	Equipment incl. transportation;
	 
	 	•	 	Bulk materials;
	 
	 	•	 	Site advisory services; and

	 	•	 	[...***...]

*** Confidential Treatment Requested

14

 

	 	 	 	[...***...], in all cases, subject to the
approval of the Board of Directors of UCA.

	C.4 	 	Proposal Costs
	 
	 	 	Notwithstanding anything contained herein to the contrary, UCA will be reimbursed by
Myriant for the reasonable costs incurred in the preparation of any proposals requested by
Myriant for any Project or Plant in accordance with Exhibit B attached hereto and made a
part hereof.
	 
	C.5 	 	[...***...]
	 
	 	 	[...***...]
	 
	C.6 	 	Process and Performance Guarantees
	 
	 	 	If an identified Project requires the provision of process and performance guarantees for
the Processes by UCA, the Parties shall discuss and negotiate in good faith upon the
structure, conditions and form of such guarantees in consideration of the reliability of the
Processes at the time of such requirement. The Parties acknowledge and have discussed in
detail the provision that any process and/or performance guarantees by UCA is explicitly
subject to the approval of UCA’s Board of Directors. The Parties understand that, for
design-build projects, Myriant envisions using a traditional project finance structure
requiring process and performance guarantees with corresponding liquidated damage provisions
as noted in Item C.3 hereinabove.
	 
	D.	 	Miscellaneous
	 
	D.1 	 	Effective Date
	 
	 	 	This Agreement shall become effective upon execution by the last Party needing to sign
this Agreement.
	 
	D.2 	 	Representation
	 
	 	 	No Party shall have the right or obligation to represent the other
Party or to enter into any obligation of whatever kind for the other
Party. The Parties are independent contractors and nothing in this
Agreement shall be deemed to constitute, create, give effect to or
otherwise recognize a joint venture, partnership, or formal business
entity of any kind and the rights and obligations of the Parties shall
be limited to those expressly set forth herein.

*** Confidential Treatment Requested

15

 

	D.3 	 	Confidentiality Agreement
	 
	 	 	The Parties shall treat all information exchanged under this Agreement as confidential
information in accordance with the Confidentiality Agreement signed between the Parties on
11 September 2009.
	 
	 	 	Neither Party shall publicly announce or disclose the existence of this Agreement or its
terms and conditions, or advertise or release any publicity regarding this association or
the Project without the prior consent of the other Party, such consent which shall not be
unreasonably withheld or delayed.
	 
	D.4 	 	Term
	 
	 	 	The Agreement shall be valid for a period of [...***...] from the time stated in Item D.1
of this Agreement (the “Term”) and shall, in consideration of any necessary
amendments according to Item C.6, continue thereafter if mutually extended by the Parties.
	 
	D.4.1 	 	Termination of Agreement
	 
	 	 	[...***...]. A Party that does not elect to renew this Agreement
shall notify the other of its intent not to renew this Agreement
before the expiry of the Term by providing the other Party 180 days
prior written notice to the other Party of its intention not to
renew.
	 
	D.4.2 	 	Termination with Immediate Effect
	 
	 	 	Either Party may terminate this Agreement — unless otherwise agreed upon between the
Parties — with immediate effect, if

	 	a)	 	insolvency, bankruptcy, liquidation, receivership or dissolution of the
other Party occurs; or
	 
	 	b)	 	the Parties do not (i) [...***...] and (ii) [...***...], or
	 
	 	c)	 	the other Party commits a material breach of any of its obligations under
the Agreement, which is not cured after notice, and a reasonable opportunity to cure
such breach.

	 	 	Except in the case of material breach, [...***...].

	D.5 	 	Cooperation in the light of Antitrust Laws
	 
	 	 	Unless the Agreement is terminated in accordance with D.4.1 or D.4.2, the Parties shall
examine the Term and exclusivity provisions of Part A.1.1 and C.5

*** Confidential Treatment Requested

16

 

	 	 	of this Agreement no later than the sixth anniversary of the Effective Date in light of
the then applicable antitrust legislation. If required, the Parties shall make necessary
revisions to the Term and/or exclusivity provisions provided for in this Agreement.

	D.6 	 	Waiver of Terms
	 
	 	 	This Agreement will not be modified except by an instrument in writing signed by or on
behalf of each Party. The failure of either Party to insist, in any one or more instances,
upon the performance of any of the terms, covenants or conditions of this Agreement or to
exercise any right hereunder, will not be construed as a waiver or relinquishment of the
future performance of any such terms, covenants or conditions or the future exercise of
such right, but the obligation of the other Party with respect to such future performance
will continue to be in full force and effect.
	 
	D.7 	 	Entire Agreement, Execution Costs, No Assignment
	 
	 	 	This Agreement and the Confidentiality Agreement referred to hereinafter in Item D.3
contains the entire agreement between the Parties with respect to the subject matter of
this Agreement and the transactions contemplated herein and it supersedes all prior
collateral communications, reports and understandings between the Parties with respect
thereto, including the Cooperation Agreement referred to hereinabove. It is understood
that this Agreement does not affect any other agreements between the Parties except those
specified herein. The Parties recognize and acknowledge that Uhde and Myriant are
concurrently entering into a parallel agreement with similar terms and conditions for all
regions of the world outside of the United States.
	 
	 	 	Each of the Parties shall bear its respective fees, costs, and expenses in connection with
the execution of this Agreement. Neither Party may assign this Agreement, in whole or in
part, or any rights hereunder without the prior written consent of the other Party, such
consent which will not be unreasonably withheld or delayed.
	 
	D.8 	 	Liability/Indemnity
	 
	 	 	DURING THE EXECUTION OF THE RESEARCH AND DEVELOPMENT PROCESS; EACH PARTY SHALL USE ITS
CUSTOMARY CARE AND DILIGENCE IN ACCORDANCE WITH THE ACKNOWLEDGED SCIENTIFIC STANDARDS AND
TECHNOLOGY.
	 
	 	 	NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY FOR THE SUITABILITY, CORRECTNESS,
COMPLETENESS OR OTHER QUALITIES OF ANY OF THEIR RESEARCH AND DEVELOPMENT RESULTS AND
INFORMATION PROVIDED TO EACH OTHER UNDER THIS AGREEMENT. THE PARTIES SHALL EXPLICITLY NOT
BE LIABLE TO EACH OTHER FOR THE FAILURE TO ACHIEVE OF ANY OF THE GOALS OF THE ALLIANCE.

*** Confidential Treatment Requested

17

 

	 	 	NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY BY WAY OF INDEMNITY OR BY REASONS OF TORT
(INCLUDING BUT NOT LIMITED TO NEGLIGENCE) OR OTHERWISE FOR ANY LOSS OF PROFIT, LOSS OF
USE, LOSS OF PRODUCTION, LOSS OF CONTRACT OR ANY FINANCIAL OR ECONOMIC LOSS OR FOR ANY
INDIRECT OR CONSEQUENTIAL DAMAGE OF WHATEVER CAUSE.
	 
	 	 	THE PARTIES’ RIGHTS AND REMEDIES AS STATED HEREIN ARE EXCLUSIVE AND IN LIEU OF ALL OTHER
REMEDIES WHETHER STATUTORY, EXPRESS OR IMPLIED AND ARE THE SOLE REMEDIES OF A PARTY FOR
THE FAILURE BY THE OTHER PARTY TO COMPLY WITH ITS OBLIGATIONS.
	 
	D.9 	 	Governing Law/Mediation/Arbitration
	 
	 	 	This Agreement shall be governed by and construed in accordance with the State of
Delaware, without giving effect to conflicts of law principles.
	 
	 	 	For any disputes between the Parties relating to Intellectual Property matters as provided
herein or that may otherwise arise between the Parties under this Agreement or in the
Alliance, the Parties shall have the option to first resort to mediation in accordance
with the Commercial Mediation Procedures of the American Arbitration Association
(“AAA”). The Parties shall jointly appoint a sole mediator who is a nationally
recognized expert in intellectual property matters to adjudicate such disputes. Failing
the joint appointment, the mediator shall be chosen by the AAA. Each Party may be
represented by counsel at the mediation, but each Party must attend through an officer
having authority to agree to a settlement at the mediation. The mediation session shall
occur in New York City, New York, and shall extend no longer than a single day. Statements
or offers made at the mediation session shall not be admissible in any later arbitration
hearing. Each Party shall bear its own expenses and an equal share of the expenses of the
mediator and the fees of the AAA. The Parties, their representatives, other participants
and the mediator shall hold the existence, content and result of the mediation in
confidence.
	 
	 	 	Any disputes arising out of or in connection with this Agreement shall exclusively and
finally be settled under the International Chamber of Commerce Rules of Arbitration (the
“ICC Rules”) of the International Chamber of Commerce (the “ICC”). The
arbitral tribunal determining any dispute shall be comprised of three arbitrators. Each
Party to a dispute shall designate one arbitrator. If a Party fails to designate an
arbitrator within a reasonable period, the ICC shall designate an arbitrator for such
Party. The two arbitrators designated by the Parties to a dispute (or, if applicable, the
ICC) shall designate a third arbitrator. In the event that the two arbitrators designated
by the Parties to a dispute (or, if applicable, the ICC) are unable to agree upon a third
arbitrator within a reasonable period, the third arbitrator shall be selected in
accordance with the ICC Rules by the ICC. The language of the arbitration shall be in
English, and the place of the arbitration of any dispute shall be Wilmington, Delaware or
any other venue as agreed upon by the Parties to

*** Confidential Treatment Requested

18

 

	 	 	such a dispute. If neither the Parties nor the arbitral tribunal can agree upon
procedures, the arbitration shall be conducted in accordance with the ICC’s procedures.
The hearings and taking of evidence of any dispute may be conducted at any locations that
will, in the judgment of the arbitral tribunal, result in a speedy, efficient and just
resolution of such dispute. The Parties to any dispute shall use their reasonable best
efforts to cooperate with each other and the arbitral tribunal in order to obtain a
resolution as quickly as possible, including by adopting the ICC’s “fast-track” procedure
(as provided for in Article 32(1) of the ICC Rules) if appropriate. Notwithstanding any
provision of this Agreement to the contrary, this Item D.9 shall be construed to the
maximum extent possible to comply with the laws of the State of Delaware, including the
Uniform Arbitration Act (10 Del. C. § 5701 et seq.) (the “Delaware
Arbitration Act”). If, nevertheless, it shall be determined by a court of competent
jurisdiction that any provision or wording of this Item D.9, including the ICC Rules,
shall be invalid or unenforceable under the Delaware Arbitration Act or other applicable
law, such invalidity shall not invalidate all of this Item D.9. In that case, this Item
D.9 shall be construed so as to limit any term or provision so as to make it valid or
enforceable within the requirements of the Delaware Arbitration Act or other applicable
law, and, in the event such term or provision cannot be so limited, this Item D.9 shall be
construed to omit such invalid or unenforceable provision.
	 	 	Notwithstanding the above, each Party acknowledges that its breach of the Agreement may
cause irreparable damage to the other Party and hereby agrees that without prejudice to
the before mentioned the other Party shall be entitled to seek injunctive relief under
this Agreement for such breach.
	 
	D.10 	 	Amendments
	 
	 	 	This Agreement may not be changed or amended orally, but only in writing signed by the
Parties hereto. The writing must refer to this Agreement and must expressly state that it
is an amendment hereof.
	 
	D.11 	 	Severability
	 
	 	 	The circumstance that any provision or part of it of this Agreement
is held to be void, illegal, unenforceable or contrary to law or
public policy shall not affect the validity of the remaining
provision(s) of this Agreement. The invalid, illegal or unenforceable
provision or part of it will be replaced by an admissible one, aiming
at the same economic and legal results.
	 
	D.12 	 	Force Majeure
	 
	 	 	No Party shall be liable, in respect to any delay in completion of
work hereunder or of the non-performance of any term or condition of
this Alliance directly or indirectly resulting from delays by Acts of
God; acts of the public enemy; strikes; lockouts; epidemic and riots;
power failure; water shortage or adverse weather conditions; or other
causes beyond the control of the Parties. In the event of any of the
foregoing, the time for performance shall be equitably and
immediately adjusted, and in no event shall any Party be liable for
any consequential or incidental damages from its performance or
non-performance

*** Confidential Treatment Requested

19

 

	 	 	of any term or condition of this Alliance. The Parties shall resume the completion of work
under this Alliance as soon as possible subsequent to any delay due to force majeure.
	 
	D.13 	 	Further Assurances.
	 
	 	 	The Parties agree and acknowledge that this Agreement grants certain
rights and responsibilities to each other and that it also provides
certain “framework” arrangements of a prospective nature between the
Parties. In that regard, the Parties may elect to enter into such other
agreements as may be necessary to reflect the intent of the Parties on a
going—forward basis.

	 	 	 	 	 
				
	Myriant Technologies LLC

	 	Uhde Corporation of America
	 
		 		 
	Quincy, MA, September 10, 2009

	 	Bridgeville, PA, September 11, 2009
	 
		 		 
	Signature: 

	/s/ Samuel G. McConnell	 	Signature: 	/s/ Dennis G. Lippmann
	 
	 	 		 
	 	Name: Samuel G. McConnell

	 	 	Name: Dennis G. Lippmann
	 	Position: Senior Vice President

	 	 	Position: President

*** Confidential Treatment Requested

20

 

Annex 1-Definitions

	 	 	 

	Affiliate(s)

	 	An Affiliate of a Party is a person or entity that directly,
or indirectly through one or more intermediaries, controls, or
is controlled by, or is under common control with, such Party.
	 
	 	 
	Agreement

	 	means this Alliance Agreement in its version as signed by both
Parties and of which each Party shall hold one original copy.
	 
	 	 
	Alliance

	 	means the relationship between the Parties contemplated by
this Agreement.
	 
	 	 
	Demonstration Plant

	 	means the contemplated Succinic Acid production facility with
an annual output of 30 million pounds to be located in the
United States.
	 
	 	 
	EP

	 	means the engineering and procurement functions for the Plants.
	 
	 	 
	Field

	 	means the field of Succinic Acid.
	 
	 	 
	Intellectual Property

	 	means any and all Intellectual Property Rights in, to, or
	 
	 	 
	Rights

	 	arising out of any (i) Patents; (ii) trade secrets; (iii)
know-how (iv) copyrights, copyright registrations, or any
national or regional application therefor, in any territory,
or any other right corresponding thereto throughout the world;
or (v) any other intellectual property or proprietary right
anywhere in the world.
	 
	 	 
	Joint Working Results

	 	means (i) improvements to the Myriant Process made by Uhde or
jointly by UCA and Myriant, (ii) improvements to the Uhde
Process made by Myriant or jointly by Uhde and Myriant, (iii)
new processes jointly developed by the two Parties, or (iv)
new processes developed solely or substantially by one of the
Parties with reference to the other Party’s intellectual
property, as such improvements or new processes are developed
within the scope of the collaboration as defined herein,
together and/or singularly, as the context may indicate.
	 
	 	 
	Myriant

	 	means Myriant Technologies LLC, a limited liability company
duly organised under the laws of Delaware with its principal
office at 1 Pinehill Drive, Batterymarch Park II, Suite 301,
Quincy, MA 02169, USA.

*** Confidential Treatment Requested

21

 

	 	 	 

	Myriant Improvement

	 	means any improvement to the Myriant Process solely developed
by Myriant without reference to any UCA or Uhde intellectual
property.
	 
	 	 
	Myriant Process

	 	means a proprietary fermentation technology developed by
Myriant [...***...].
	 
	 	 
	Patent

	 	means any and all rights under any of the following, whether
existing now or in the future: (i) all national, regional and
international patents and patent applications, including
provisional patent applications, utility model, design
registration, certificate of invention, patent of addition or
substitution, or other governmental grant for the protection
of inventions or industrial designs anywhere in the world,
including any reissue, renewal, re-examination or extension
thereof; and (ii) any application for any of the foregoing,
including any international, provisional, divisional,
continuation, continuation-in-part, or continued prosecution
application.
	 
	 	 
	Pilot Plant

	 	means the Fermic Sa de CV’s tolling facility in Mexico City,
Mexico configured and contracted by Myriant for the production
of Succinic Acid at a semi-industrial scale.
	 
	 	 
	Plant(s)

	 	means commercial scale Succinic Acid production facility(ies)
located in the United States utilizing the Processes.
	Prior IP Record

	 	means any Patent application; document substantiating the
existence of a trade secret, proprietary technology or
know-how; copyrighted work; copyright registration;
engineering lab book, record or drawing, or any national or
regional application therefor.
	 
	 	 
	Project

	 	means that series of activities and tasks in support of the
financing, siting, design, engineering, construction
procurement and/or operation of commercial scale Plants
utilizing the Processes.
	 
	 	 
	Processes

	 	means the Myriant Process together with the Uhde Process when
the context so indicates.
	 
	 	 
	Steering 

Committee

	 	means the Alliance steering committee comprised of
four (4) members with equal representation by Myriant and UCA.
	 
	 	 
	UCA

	 	means Uhde Corporation of America, a company duly organised
under the laws of Delaware with its principal office at 1370
Washington Pike, Bridgeville, PA 15017, USA.

*** Confidential Treatment Requested

22

 

	 	 	 

	Uhde

	 	means Uhde GmbH, a company duly organised under the laws of
the Federal Republic of Germany with its principal office at
Friedrich-Uhde-Str. 15, 44141 Dortmund.
	 
	 	 
	Uhde Improvement

	 	means any improvement to the Uhde Process solely developed by
Uhde or UCA without reference to any Myriant intellectual
property.
	 
	 	 
	Uhde Process

	 	means a proprietary separation technology developed by Uhde
[...***...]
	 
	 	 
	Joint Working Results

	 	means (i) improvements to the Myriant Process made by Uhde or
by Myriant and Uhde jointly, (ii) improvements to the Uhde
Process made by Myriant or by Myriant and Uhde jointly, (iii)
new processes jointly developed by the two Parties, or (iv)
new processes developed solely or substantially by one of the
Parties but with reference to the other Party’s intellectual
property, as such improvements or new processes are developed
within the scope of the collaboration as defined herein,
together and/or singularly, as the context may indicate.

*** Confidential Treatment Requested

23

 

EXHIBIT A — Uhde Process License Fee Structure

	 	 	License Fee in EUR:

	 	•	 	for capacities below [...***...] MT/year: [...***...]
	 
	 	•	 	for capacities between [...***...] and [...***...] MT/year:

	 	•	 	[...***...]
	 
	 	•	 	[...***...]

	 	•	 	for capacities above [...***...] MT/year: to be discussed.

*** Confidential Treatment Requested

24

 

EXHIBIT B — Engineering and Plant Proposal Fees

	For Engineering Services including Plant Proposal services provided by UCA under this
Agreement, Myriant shall pay to UCA the following hourly rates:

	a)	 	for home office engineering performed in UCA’s home office in Bridgeville,
PA: USD (to be indicated, if applicable);
	 
	b)	 	for home office engineering performed by UCA through Uhde: [...***...];
	 
	c)	 	for home office engineering performed by UCA through Uhde Engineering de
Mexico S.A. de C.V.: [...***...]; and
	 
	d)	 	for assignment of personnel out of home office, the Parties shall agree on
daily rates including incidental cost in due course.

The rates indicated under a) through c) above are based on 40 working hours/week (Mon-Fri)
and shall be valid until 30.09.2010. Thereafter, the rates shall be escalated on the first
date of each subsequent year in accordance with the increase of salaries and incidental
salary expenses as substantiated by UCA.

The above rates may differentiate between different categories and different UCA offices.

The Parties shall mutually agree at agreed intervals on which rates shall be applied to
which work packages.

Additional cost, e.g. travel and accommodation cost in case of business trips, etc., shall
be reimbursed in addition to the above rates.

The above mentioned rates shall be invoiced by UCA on a monthly basis and shall be payable
within 30 days after receipt of invoice.

Compensation for Supplies

[...***...], shall be mutually agreed prior to start engineering of Demonstration Plant.

*** Confidential Treatment Requested

25

 

EXHIBIT C — [...***...]

[...***...]

*** Confidential Treatment Requested

26exv10w3

Exhibit 10.3

*** Text Omitted and Filed Separately

Confidential Treatment Requested

Under 17 C.F.R. §§ 200.80(b)(4)

and 203.406

Global Alliance Agreement

by and between

Uhde GmbH

and

Myriant Technologies LLC

 

			
	***	 	Confidential Treatment Requested

 

 

TABLE OF CONTENTS

	 	 	 	 	 

	Global Alliance Agreement
	 	 	1	 
	Recitals
	 	 	1	 
	A. Alliance Structure
	 	 	2	 
	A.1 General Structure and Purposes of the Alliance
	 	 	2	 
	A.1.1 Exclusive Alliance Arrangements
	 	 	2	 
	A.2 Conduct and Governance of the Alliance
	 	 	3	 
	A.3 Costs
	 	 	4	 
	A.4 Exchange of Information
	 	 	4	 
	B Joint Research and Development and Intellectual Property
	 	 	4	 
	B.1 Rights to the Processes
	 	 	4	 
	B.2 Intellectual Property Ownership
	 	 	5	 
	B.2.1 Myriant Rights
	 	 	5	 
	B.2.2 Uhde Rights
	 	 	5	 
	B.3 Improvements and Working Results
	 	 	5	 
	B.3.1. Myriant Improvements
	 	 	5	 
	B.3.2 Uhde Improvements
	 	 	6	 
	B.3.3 Joint Working Results
	 	 	6	 
	B.4 Use and License Rights
	 	 	7	 
	B.4.1 Myriant Grant of Use Rights to Uhde
	 	 	7	 
	B.4.2 Uhde Grant of Use Rights To Myriant
	 	 	7	 
	B.4.3 Uhde Grant of Uhde Process Plant Licenses
	 	 	7	 
	B.4.4 Uhde Process License Fee
	 	 	7	 
	B.4.5 Myriant Grant of Sublicense Rights
	 	 	8	 

 

			
	***	 	Confidential Treatment Requested

 

 

	 	 	 	 	 

	B.4.6 Uhde Grant of Sublicense Rights
	 	 	8	 
	B.5 Application of Intellectual Property Rights and Maintenance
of Intellectual Property Rights
	 	 	9	 
	B.5.1. Application for Intellectual Property Rights
	 	 	9	 
	B.5.2. Costs
	 	 	9	 
	B.5.3. Notice Rights
	 	 	9	 
	B.5.4. Joint Filing of Application
	 	 	9	 
	B.5.5. Separate Application of Either Party
	 	 	10	 
	B.5.6 Maintenance of IP Rights
	 	 	10	 
	B.5.7 Laws on Employees’ Invention
	 	 	10	 
	B.5.8 Claiming of Employees’ Inventions
	 	 	10	 
	B.6. Infringement of Intellectual Property Rights
	 	 	10	 
	B.6.1 Information about Possible Infringements
	 	 	10	 
	B.6.2 Defense
	 	 	11	 
	B.6.3 Information about Charges and Mutual Support
	 	 	11	 
	B.6.4 Charges by other Party
	 	 	11	 
	B.7 Termination of the Agreement
	 	 	11	 
	B.7.1 Ownership
	 	 	11	 
	B.7.2 Continuing Rights to Working Results upon Termination
	 	 	12	 
	B.7.3 Licensing of Joint Working Results
	 	 	12	 
	B.7.4 Licensing of Separate IP Rights
	 	 	12	 
	B.7.5 Maintenance of IP Rights
	 	 	12	 
	B.7.6 Sale of IP Rights
	 	 	12	 
	B.8 Compensation
	 	 	13	 

 

			
	***	 	Confidential Treatment Requested

 

 

	 	 	 	 	 

	C. Project Marketing
	 	 	13	 
	C.1 Activities
	 	 	13	 
	C.2 Business Development Projects
	 	 	13	 
	C.3 Proposal Development
	 	 	14	 
	C.4 Proposal Costs
	 	 	16	 
	C.5 [...***...]
	 	 	16	 
	C.6 Process and Performance Guarantees
	 	 	16	 
	D. Miscellaneous
	 	 	16	 
	D.1 Effective Date
	 	 	16	 
	D.2 Representation
	 	 	16	 
	D.3 Confidentiality Agreement
	 	 	17	 
	D.4 Term
	 	 	17	 
	D.4.1 Termination of Agreement
	 	 	17	 
	D.4.2 Termination with Immediate Effect
	 	 	17	 
	D.5 Cooperation in the Light of Antitrust Laws
	 	 	18	 
	D.6 Waiver of Terms
	 	 	18	 
	D.7 Entire Agreement, Execution Costs, No Assignment
	 	 	18	 
	D.8 Liability/Indemnity
	 	 	19	 
	D.9 Governing Law/Mediation/Arbitration
	 	 	19	 
	D.10 Amendments
	 	 	20	 
	D.11 Severability
	 	 	20	 
	D.12 Force Majeure
	 	 	20	 
	D.13 Further Assurances
	 	 	21	 

 

			
	***	 	Confidential Treatment Requested

 

 

	 	 	 	 	 

	Annex 1-Definitions
	 	 	22	 
	 
	 	 	 	 
	Exhibit A — Uhde Process License Fee Structure
	 	 	25	 
	Exhibit B — Engineering and Plant Proposal Fees
	 	 	26	 
	Exhibit C — [...***...]
	 	 	27	 

 

			
	***	 	Confidential Treatment Requested

 

 

Global Alliance Agreement

This Global Alliance Agreement (the “Agreement”) by and between Uhde GmbH, a German
company with its principal offices located at Friedrich-Uhde-Str. 15, 44141 Dortmund (hereinafter
referred to as “Uhde”) and Myriant Technologies LLC, a Delaware limited liability company,
with its principal offices located at 1 Pinehill Drive, Batterymarch Park II, Suite 301, Quincy, MA
02169 USA (hereinafter referred to as “Myriant”); each of Uhde and Myriant are singularly
also referred to herein as “Party” and jointly as “Parties” (certain capitalized terms shall have
the meaning ascribed to them as set forth in Annex 1 attached hereto and made a part hereof).

Recitals

WHEREAS, Uhde is an internationally recognized engineering and procurement company active in the
field of chemical, refining, petrochemical and other industrial plants, owns different proprietary
technologies and has extensive know-how and experience in the engineering, procurement and
construction of such technology related plants;

WHEREAS, Myriant is a science and technology company active in the development and
commercialization of next generation biorefineries for the production of bio-based chemicals and
fuels from renewable feedstocks, possesses the know-how to produce such fuels and chemicals, and is
developing a proprietary fermentation process for the production of Succinic Acid (herein referred
and hereinafter defined as the “Myriant Process”);

WHEREAS, Uhde and Myriant intend to exclusively cooperate in their research and development efforts
(the “Joint R&D”) hereunder to jointly develop and optimize the “Myriant Process” and the
“Uhde Process” (as defined herein) for the production of Succinic Acid in the “Pilot Plant” (as
defined herein) and future “Plants” (as defined herein), and the Parties shall license their
respective processes to each other on a royalty-free basis solely in furtherance of this objective;

WHEREAS, Uhde and Myriant intend to exclusively cooperate in their business development efforts
(the “Project Marketing”) to market, jointly develop, bid and execute “Projects” (as
defined herein) for the design, engineering, and procurement of commercial scale Succinic Acid
Plants worldwide (except for the United States) incorporating their respective processes;

WHEREAS, Myriant intends to use Uhde exclusively for engineering and as its engineering,
procurement and construction contractor for commercial-scale Succinic Acid plants worldwide (except
for the United States) incorporating their respective processes;

WHEREAS, Uhde has the know-how to isolate organic acids and has developed separation technology for
the isolation of Organic Acids, including Succinic Acid (herein referred to and hereinafter defined
as the “Uhde Process”);

WHEREAS, Uhde has licensed to “UCA” (as defined hereunder), an Affiliate of Uhde, the Uhde Process
for use in the United States and has granted it the right to license

 

			
	***	 	Confidential Treatment Requested

1

 

and sublicence the Uhde Process, Uhde Improvements, and Joint Working Results solely for use
within the United States to Myriant in a parallel agreement know as the “Alliance Agreement between
Uhde Corporation of America and Myriant Technologies LLC” dated as of September 11, 2009 (the
“U.S. Alliance Agreement”);

WHEREAS, except as otherwise provided in the US Alliance Agreement, Uhde intends to licence such
Process to Myriant for use worldwide (except for the United States) in (i) any “Plants” (as defined
hereunder) for which Uhde shall be providing “process and performance guarantees” in accordance
with the license fees payable hereunder for such use; and (ii) those limited situations in which
Uhde will not be acting as the EPC or EP Plant contractor on mutually acceptable terms and
conditions to be agreed upon by Uhde and Myriant;

WHEREAS, UCA and Myriant are concurrently entering into the U.S. Alliance Agreement, with similar
terms and conditions valid for the United States only;

Now, therefore, in consideration of the foregoing and for good and other valuable consideration,
the mutual receipt and sufficiency of which is hereby acknowledged. the Parties hereto agree to the
following, which shall govern their cooperation:

A. ALLIANCE STRUCTURE

	A.1  	 	General Structure and Purposes of the Alliance
	 
		 	a) The Alliance shall be based upon the Parties’ joint research and development efforts to
collaborate exclusively with each other to integrate and deploy the “Processes” (as
defined herein) in the Pilot Plant and future Plants (located outside of the United
States) during the “Term” (as defined herein) hereof. The Parties envision that they
shall first deploy the Processes in the proposed Pilot Plant, which shall be operated by
Myriant or its agents.
	 
		 	b) During the later stages of the Term, and subject to the conditions provided herein, the
Parties shall cooperate in “Project Marketing,” which shall include, without limitation,
the development of Projects and construction of Plants (located outside of the United
States) that Myriant or its Affiliates may (i) own, lease, operate or manage, (ii) supply
products to the end customer(s) and/or (iii) have the contractual relationship for such
supply of the Plant’s products to the end customer(s) and in which Uhde shall act as its
exclusive engineering, procurement and construction contractor.
	 
		 	c) Myriant and Uhde will each assign experienced personnel to the Alliance for the purpose
of advancing the purposes of the Alliance, including the Joint R&D and Project Marketing
as detailed herein. Myriant shall perform Project Marketing with regard to the end
customer(s) with reasonable technical assistance provided by Uhde and/or its Affiliates.
	 
	A.1.1  	 	Exclusive Alliance Arrangements
	 
		 	a) Except as otherwise provided in Item C.2.e, Uhde or one of its Affiliates shall perform
its services as Myriant’s either exclusive engineering,

 

			
	***	 	Confidential Treatment Requested

2

 

	 	 	procurement and construction contractor (“EPC”) or, as the case may be, its
exclusive engineering and procurement contractor (“EP”) for any Plants located
worldwide (except for the United States) during the Term hereof, provided,
however, that Myriant may, subject to the Item C.2.e, individually pursue Projects
only where (i) Uhde has affirmatively elected and advised Myriant in writing of its
decision not to pursue a Project jointly with Myriant; or (ii) Uhde is unable to proceed
on a Project because of its inability to provide Project process and performance
guarantees acceptable to the particular Project lender; further, provided,
however, that Myriant shall only proceed to use the Uhde Process for such Projects
in accordance with Item B.4.3 hereof and further, provided,
however, that the provision of [...***...]. Uhde, on the other hand, shall not in any case during the Term
hereof, pursue any Project without Myriant.
	 
		 	b) Myriant and its Affiliates, subject to the exceptions provided herein, will not enter
into discussions or negotiations with, solicit a proposal from, or consider any
unsolicited proposal from any other EP contractors for Projects. Uhde and its Affiliates,
subject to the exceptions provided herein, will not enter into discussions or negotiations
with, solicit a proposal from, or consider any unsolicited proposal from any other third
party for the realization of Projects; provided, however, that it is
expressly agreed between the Parties that Uhde remains free to provide and to actively
market the Uhde Process and, within the restrictions of Item B.4.5, Myriant Intellectual
Property Rights to any third party for plants worldwide (except for the United States)
that are not intended to produce Succinic Acid.
	 
	A.2  	 	Conduct and Governance of the Alliance
	 
		 	a) The Parties will establish an Alliance steering committee with four (4) members with
equal representation by Myriant and Uhde (the “Steering Committee”).
	 
		 	b) The Steering Committee shall convene in person, by videoconference or telephonically
on no less than a quarterly basis, and on shorter notice if circumstances dictate, to
review the performance of the Alliance, address any issues or disputes and take such other
actions as may advance the purposes of the Alliance. The Steering Committee shall have
such other responsibilities as set forth herein and shall also review and recommend
specific Projects for bid to the Parties, decide whether or not to bid for a specific
Project, and decide on further research and development work in connection with the
Processes.
	 
		 	c) The Parties will establish a project team (the “Project Team”), with equal
representation by Myriant and Uhde. The Project Team’s basic functions shall be:

	 	i 	 	development of the upstream and downstream Processes, including the
harmonization of the economics on both Parties’ sides,

 

			
	***	 	Confidential Treatment Requested

3

 

	 	ii 	 	 selection of technologies to be used for future Plants (located outside
of the United States), and
	 
	 	iii 	 	 oversight and coordination of design, construction and start-up of new
Plants (located outside of the United States).

	A.3  	 	Costs
	 
	 	 	Except with respect to Uhde’s Project Proposal preparation costs as provided in Item C.4,
each Party shall bear its respective fees, costs, and expenses for all of the activities
of the Alliance, including for Joint R&D and Project Marketing. The Parties shall not
share any additional expense or cost in connection with efforts (e.g., for joint
developments, employment of external third parties etc.), unless specifically agreed to in
writing in advance by duly authorized representatives of the Parties.
	 
	A.4  	 	Exchange of Information
	 
	 	 	Each Party shall promptly inform and update each other of its progress in the research and
development of its respective Process, unless rights of third parties prevent such
disclosure of information. Further, the Parties shall collaborate with each other and
share their respective expertise to solve any problems or questions that may arise in the
course of the joint research and development work.
	 
	B JOINT RESEARCH AND DEVELOPMENT AND INTELLECTUAL PROPERTY 
	 
	B.1  	 	Rights to the Processes

	 	a)	 	Uhde. Uhde hereby represents and warrants to Myriant that as of the Effective
Date:

	 	i 	 	All requisite corporate action on the part of Uhde and on the part of
each of its officers and directors necessary for the authorization and execution of
this Agreement and the performance of its obligations hereunder has been taken.
	 
	 	ii 	 	 This Agreement is the legal, valid and binding obligation of Uhde,
enforceable against it in accordance with its terms.
	 
	 	iii 	 	 Uhde (a) has the rights to grant to Myriant the license rights set
forth in Section B herein and (b) has granted to UCA the necessary license rights
allowing UCA to grant to Myriant the required sublicenses under the U.S. Alliance
Agreement.
	 
	 	iv  	 	No claim is pending, or to the best knowledge of Uhde, has been
threatened in writing against Uhde or its Affiliates challenging Uhde’s right of
use or ownership of the Uhde Process or to grant the licenses to the Uhde Process
pursuant to this Agreement or any other agreement licensing the Uhde Process to a
third party.

 

			
	***	 	Confidential Treatment Requested

4

 

	 	b)	 	Myriant. Myriant hereby represents and warrants to Uhde that as of the
Effective Date:

	 	i 	 	All requisite corporate action on the part of Myriant and on the part
of each of its officers and directors necessary for the authorization and execution
of this Agreement and the performance of its obligations hereunder has been taken.
	 
	 	ii 	 	 This Agreement is the legal, valid and binding obligation of Myriant,
enforceable against it in accordance with its terms.
	 
	 	i 	 	Myriant has the rights to grant to Uhde the license rights set forth in
Section B herein.
	 
	 	ii 	 	 No claim is pending, or to the best knowledge of Myriant, has been
threatened in writing against Myriant or its Affiliates challenging Myriant’s right
of use or ownership of the Myriant Process or to grant the licenses to the Myriant
Process pursuant to this Agreement.

	B.2  	 	Intellectual Property Ownership
	 
	B.2.1  	 	Myriant Rights
	 
	 	 	Myriant owns or is the licensee of all right, title and interest
in and to any pre-existing Intellectual Property Rights to the
Myriant Process, including any Prior IP Record. As between the
Parties, Myriant has the exclusive right, at its sole discretion
and expense, to apply for, register, maintain and enforce Patents
and other Intellectual Property Rights as it deems appropriate with
respect to any of the pre-existing Intellectual Property Rights it
has to the Myriant Process.
	 
	B.2.2  	 	Uhde Rights
	 
	 	 	Uhde owns or is the licensee of all right, title and interest in
and to any pre-existing Intellectual Property Rights to the Uhde
Process, including any Prior IP Record. As between the Parties,
Uhde has the exclusive right, at its sole discretion and expense,
to apply for, register, maintain and enforce Patents and other
Intellectual Property Rights as it deems appropriate with respect
to any of the pre-existing Intellectual Property Rights it has to
the Uhde Process.
	 
	B.3  	 	Improvements and Working Results
	 
	B.3.1.  	 	Myriant Improvements
	 
	 	 	Myriant Improvements, as such Improvements are described herein
and in any Prior IP Record, shall be the sole property of Myriant,
and all rights, including Intellectual Property Rights, shall vest
solely in Myriant. Accordingly, Myriant hereby licenses to Uhde
any and all right, title and interest in and to any Myriant
Improvements pursuant to this Item B.3.1 to the extent necessary
for Uhde to complete any of the tasks contemplated herein

 

			
	***	 	Confidential Treatment Requested

5

 

	 	 	for the Term of this Agreement. Uhde agrees to execute documents, render such reasonable
assistance, and take such other reasonable action at Myriant’s expense as Myriant may
reasonably request to apply for, registered, perfect, confirm and protect any Myriant
Improvements it conceives under this Item B.3.1.
	 
	B.3.2  	 	Uhde Improvements
	 
	 	 	Uhde Improvements, as such Improvements are described herein and in
any Prior IP Record, shall be the sole property of Uhde, and all
rights, including Intellectual Property Rights, shall vest solely in
Uhde. Accordingly, Uhde hereby licenses to Myriant any and all
right, title and interest in and to any Uhde Improvements pursuant
to this Item B.3.2 to the extent necessary for Myriant to complete
any of the tasks contemplated herein for the Term of this Agreement.
Myriant agrees to execute documents, render such reasonable
assistance, and take such other reasonable action at Uhde’s expense
as Uhde may reasonably request to apply for, registered, perfect,
confirm and protect any Working Results it conceives under this Item
B.3.2.
	 
	B.3.3  	 	Joint Working Results
	 
	 	 	Joint Working Results shall be the joint property of both Parties,
and the rights for such Working Results shall vest jointly in both
Parties as provided herein (as defined hereinafter in Annex 1, the
“Joint Working Results”). Each Party agrees to grant, and hereby
does grant, usage rights to the other Party for any Joint Working
Result for any purposes contemplated under this Agreement. Further,
each Party shall not impair the other Party’s right to use the Joint
Working Results for any such purposes.
	 
	 	 	Notwithstanding the foregoing, the Steering Committee of the Parties
shall consider [...***...],
including [...***...] between the
Parties, when determining [...***...]. [...***...].
	 
	 	 	Any allocation of license fees by the Steering Committee shall be
distributed between the Parties in proportion to each Party’s
contribution and in only one of the following three proportions:

	 	a)	 	[...***...]% to the Party judged by the
Steering Committee to have made the primary contribution to the Joint
Working Results (the “Primary Developer”) and 25% to the Party
judged by the Steering Committee to have made a lesser contribution
(the “Secondary Developer”);
	 
	 	b)	 	[...***...]% to each Party in the event that
both Parties are judged by the Steering Committee to have made equal
contributions or in the event that the Steering Committee cannot
determine within a reasonable time the respective contributions of the
Parties, or

 

			
	***	 	Confidential Treatment Requested

6

 

	 	c)	 	[...***...]% to the Primary Developer in the
event that the Steering Committee determines (1) that the Primary
Developer made an overwhelming contribution to the Joint Working
Results and/or (2) that the contribution consists solely of an Uhde
Improvement or a Myriant Improvement.

	 	 	 	The Steering Committee shall also consider the respective efforts that the Parties take in
the commercialization of the Joint Working Results when making any adjustments to the
foregoing allocation of the license fees. The Steering Committee shall also determine
whether to make any downward adjustments to the Uhde License Fee charged by Uhde to
Myriant as set forth in Exhibit A hereto based on any contributions to the Joint Working
Results made by Myriant.
	 
	 	 	 	In the event of a dispute in which one party claims to have made 100% of the contribution
and the other party claims to have made more than a de minimis contribution to the Joint
Working Results, the Parties shall refer the matter to the intellectual property rights
mediator as provided for in Item D.9.

	B.4  	 	Use and License Rights
	 
	B.4.1  	 	Myriant Grant of Use Rights to Uhde
	 
	 	 	Subject to any existing third party licensing restrictions, Myriant
hereby grants to Uhde a worldwide (except for the United States),
non-exclusive, royalty-free right and license for Myriant’s
pre-existing Intellectual Property Rights, the Myriant Process, any
Myriant Improvement, and any Joint Working Results during the Term
solely for the Project’s purposes and development.
	 
	B.4.2  	 	Uhde Grant of Use Rights To Myriant
	 
	 	 	Subject to any existing third party licensing restrictions, Uhde
hereby grants to Myriant a worldwide (except for the United States),
non-exclusive, royalty-free right and license for Uhde’s
pre-existing Intellectual Property Rights, the Uhde Process, any
Uhde Improvement, and any Joint Working Results during the Term,
solely for the Project’s purposes and development.

 

			
	***	 	Confidential Treatment Requested

7

 

	B.4.3  	 	Grant of Uhde Process Licenses
	 
	 	 	Uhde hereby grants to Myriant (i) an exclusive, royalty-free right
and license to use the Uhde Process, any Uhde Improvement and any
Joint Working Result for use in the Pilot Plant, (ii) a worldwide
exclusive right and license to use the Uhde Process and any Uhde
Improvement for any Plants where Uhde is providing “process and
performance guarantees” in accordance with Item C.6, subject to the
license fee payable to Uhde in accordance with Item B.4.4, and (iii)
a [...***...].
	 
	B.4.4  	 	Uhde Process License Fee
	 
	 	 	For the right to use the Uhde Process and any Uhde Improvement in accordance with Item
B.4.3(ii) above, Myriant shall pay to Uhde per Project in accordance with the license fee
structure described on Exhibit A attached hereto and made a part hereof. The license fee
shall be subject to adjustment in accordance with Item B.3 hereof. Notwithstanding
anything provided herein to the contrary, in no case shall Myriant be required to pay
duplicate royalties for one and the same Project to both Uhde and UCA for the right to
use, license, or sublicense Uhde and/or UCA’s Intellectual Property Rights.
	 
	B.4.5  	 	 Myriant Grant of Sublicense Rights
	 
	 	 	Myriant hereby grants Uhde a perpetual, non-exclusive, worldwide
(except for the United States) right and license, including the
right to grant and authorize sublicenses, under Myriant Intellectual
Property Rights other than to its Joint Working Results, including
rights in and to the Myriant Process and any Myriant Improvement;
provided that Uhde obtains prior written approval from Myriant, such
approval which may be granted at Myriant’s sole discretion, and
provided further that for each particular sublicense, the Steering
Committee shall agree on the principal terms and conditions of any
such sublicense, including the terms and conditions and the royalty
rate. With respect to Joint Working Results, [...***...].
	 
	B.4.6  	 	Uhde Grant of Sublicense Rights
	 
	 	 	Uhde hereby grants Myriant a perpetual, non-exclusive, worldwide
(except for the United States) right and license, including the
right to grant and authorize sublicenses, under Uhde Intellectual
Property Rights other than to its Joint Working Results, including
rights in and to the Uhde Process and any Uhde Improvement, provided
that Myriant obtains prior written approval from Uhde for any
sublicenses (which shall not be unreasonably withheld or delayed
where Uhde is not acting as either the EPC or the EP contractor in
accordance with Item A.1.1(i) and (ii)), and further provided that
for each particular sublicense, the Steering Committee shall agree
on the principal

 

			
	***	 	Confidential Treatment Requested

8

 

	 	 	terms and conditions of each such sublicense, including the term and the royalty rate. In
the case where Uhde is not acting as the EPC or EP contractor in accordance with Item
A.1.1(i) and (ii), if the Parties are unable to agree on such terms and conditions, then
the matter may be referred to the intellectual rights mediator for resolution as provided
for in Item D.9. With respect to Joint Working Results, [...***...].
	 
	B.5  	 	Application of Intellectual Property Rights and Maintenance of
Intellectual Property Rights
	 
	B.5.1  	 	Application for Intellectual Property Rights
	 
	 	 	In the case that any development or a part of it which is entered
into the project by either Party, and which this Party developed
without reference to information of the other Party, can be
protected by Intellectual Property Rights, either Party shall
promptly enter such application to the respective authorities.
Either Party shall refrain from applying for any Intellectual
Property Rights for such development or information or parts of such
development or information which is provided by the other Party,
unless agreed to by both Parties and filed jointly under the
provisions of Item B.5.4.
	 
	B.5.2  	 	Costs
	 
	 	 	The costs for the application, receipt and maintenance of such
Intellectual Property Rights shall be borne by that Party that
applies for such rights.
	 
	B.5.3  	 	Notice Rights
	 
	 	 	The Party applying for any Intellectual Property Rights (the
“Applying Party”) shall inform the other Party (the “Non-Applying
Party”) immediately after applying, filing or registration of such
rights so as to give the other Party the opportunity to have its
business interests addressed by having the Applying Party add any
issues to the application that the Non-Applying Party may request to
have its business interests sufficiently covered. An Applying Party
shall also notify the Non-Applying Party if it intends to disregard,
diminish or otherwise restrict the scope of any claims to
Intellectual Property Rights in an application, filing or
registration process for any Intellectual Property Rights. The
Applying Party shall notify the Non-Applying Party for any such
action in the course of a grant, appeal or complaint process, if the
interests of the other Non-Applying Party may be, or are affected
by, such action.
	 
	B.5.4  	 	Joint Filing of Application
	 
	 	 	In the case of filing for Intellectual Property Rights according to
Item B.5.1 above the Parties shall jointly file the application for
having their Intellectual Property Rights registered. The costs for
such joint application, filing and/or registration shall be borne by
both Parties jointly and equally. With respect to any such filing,
the Parties shall mutually decide on the territorial/regional extent
of their application. If either Party is explicitly not interested
in applying for Intellectual Property Rights in any country or
region, the other Party shall

 

			
	***	 	Confidential Treatment Requested

9

 

	 	 	be free to apply for Intellectual Property Rights in that country/region without the
participation of the Party forgoing the opportunity to apply for such Rights. In such a
case and for such countries/regions, the Applying Party shall be the sole possessor of the
Intellectual Property Rights it applies for and shall bear all additional costs arising
out of any such applications. The Non-Applying Party shall nevertheless have a
non-exclusive right to use such Intellectual Property Rights.
	 
	B.5.5  	 	Separate Application of Either Party
	 
	 	 	If a Party is not interested in applying for Intellectual Property
Rights, it shall give the other Party sufficient time to apply for
and obtain such Intellectual Property Rights at any place the
Applying Party contemplates making a filing related to its
Intellectual Property Rights. Upon receipt of such notice, the
Applying Party shall have the right, at its own cost, to assume the
prosecution and maintenance with respect to such Intellectual
Property Right, as applicable, and the Non-Applying Party shall
assign all of its right, title and interest in and to such
Intellectual Property Right, or claim thereof, as applicable, to the
Applying Party. The Applying Party shall bear all costs and
obligations for any separate applications that it may elect to make
pursuant to this Item B.5.5.
	 
	B.5.6  	 	Maintenance of IP Rights
	 
	 	 	If a Party is not interested in maintaining an Intellectual Property
Right that it possesses, it shall give the other Party sufficient
time to analyze and consider whether it wishes to have the
Intellectual Property Right assigned or otherwise transferred to it
so that it may maintain the Intellectual Property Right. In the
event that the other Party decides to maintain such an Intellectual
Property Right, the Party in possession of such Intellectual
Property Right shall transfer it to the other Party.
	 
	B.5.7  	 	Laws on Employees’ Invention
	 
	 	 	The Parties shall claim inventions of their employees conceived in
the course of the collaboration contemplated by this Agreement
according to the national laws applicable to employees’ invention as
defined in Item D.9 hereunder, unless both Parties declare that they
do not have any interest in the invention.
	 
	B.5.8  	 	Claiming of Employees’ Inventions
	 
	 	 	Either Party shall arrange to obtain all rights, title and interest
in and to any inventions made by its own employees on its own. The
respective Party shall, however, coordinate with the other Party, if
such invention falls under the provisions of Items B.3.1, B.3.2, or
B.3.3. In the case of Working Results, the Party whose employees did
not contribute any inventions shall compensate the other Party for
making use of inventions made by the other Party’s employees
according to the applicable national laws governing rights with
respect to employees’ inventions.

 

			
	***	 	Confidential Treatment Requested

10

 

	B.6  	 	Infringement of Intellectual Property Rights
	 
	B.6.1  	 	Information about Possible Infringements
	 
	 	 	The Parties shall inform each other without undue delay about any
suspected infringement of Intellectual Property Rights that may be
subject to or in connection with anything provided for under this
Agreement.
	 
	B.6.2  	 	Defense
	 
	 	 	The owner or licensor of the Intellectual Property Right that a
third party allegedly infringes shall defend its Intellectual
Property Right against such third party infringement. The Parties
shall coordinate their proceedings in such matters.
	 
	 	 	In the case that legal proceedings are taken against it, the Party
defending itself shall bear all costs related to its defense. The
costs incurred by a Party joining as a third-party defendant to such
a proceeding shall be borne by the Party thus joining.
	 
	B.6.3  	 	Information about Charges and Mutual Support
	 
	 	 	In the event a Party is alleged to have breached an Intellectual Property Right that is
related to or based on this Agreement, the allegedly infringing Party shall immediately
inform the other Party thereof. The other Party shall be entitled to join any legal
proceedings in the defense of such claims by third parties. The Party not addressed by
such claim shall be obliged to reasonably cooperate with the other Party.
	 
	B.6.4  	 	Charges by other Party
	 
	 	 	If (i) either Party, or its Affiliates, make or file a claim against the other Party for a
breach of Intellectual Property Rights that are subject to or arise in connection with
this Agreement, or (ii) a Party, or its Affiliates, support a third party in making a
claim for breach of Intellectual Property Rights, the other Party may terminate this
Agreement with immediate effect.
	 
	 	 	Upon effectiveness of the termination under this Item the Parties lose the right to use
the Intellectual Property Rights of the other Party as well as the Working Results of the
other Party. The terminating Party has to return to the other Party all information, such
as but not limited to documents, data, specimen etc. referring to the said Intellectual
Property Rights and for those Working Results which are the sole property of the other
Party, as far and if the terminating Party has received any of these from the other Party.
	 
	 	 	The Joint Working Results shall be dealt with according to Item B.7.3 below.
	 
	B.7  	 	Termination of the Agreement
	 
	B.7.1  	 	Ownership

 

			
	***	 	Confidential Treatment Requested

11

 

	 	 	Upon effectiveness of termination of this Agreement, each Party shall remain owner of its
pre-existing Intellectual Property Rights, including any Prior IP Record, as provided for
in Items B.2.1 and B.2.2.
	 
	B.7.2  	 	Continuing Rights to Joint Working Results upon Termination
	 
	 	 	In the event of the election by both Parties to mutually terminate this Agreement prior to
the expiration of the Term, the Steering Committee shall meet to [...***...]. The
Steering Committee shall consider all relevant factors [...***...]. In the event that the
Steering Committee is unable to reach a determination of the Parties’ respective rights,
the Parties may refer the issue to the intellectual property mediator for resolution
pursuant to the mechanism provided for in Item D.9. In the event of a termination of this
Agreement arising out of a material breach by one of the Parties hereto, [...***...]. If
the Parties dispute the existence of a material breach, the Parties shall refer the matter
to arbitration as provided for in Item D.9.
	 
	B.7.3  	 	Licensing of Joint Working Results
	 
	 	 	In the event that this Agreement is terminated for any reason other
than a material breach, [...***...]; provided, however, that for
each particular sublicense, the Steering Committee shall
[...***...]. If the Parties are unable to agree on such terms and
conditions, then the matter may be referred to the intellectual
rights mediator for resolution as provided for in Item D.9.
	 
	B.7.4  	 	Licensing of Separate IP Rights
	 
	 	 	The Steering Committee shall negotiate and agree on reasonable
license fees and other terms and conditions for those Intellectual
Property Rights that are the sole property of either Party and to
which the other Party requires access to continue its research and
marketing activities.
	 
	B.7.5  	 	 Maintenance of IP Rights
	 
	 	 	Upon effectiveness of the termination, neither Party shall be
obliged to maintain its patents or patent applications, irrespective
of these being joint or own patents or patent applications.
	 
	B.7.6  	 	Sale of IP Rights
	 
	 	 	If either Party decides to sell any of its Intellectual Property Rights, the other Party
shall have a pre-emptive right to buy this Intellectual Property Right from that Party at
a reasonable price to be negotiated between the Parties in good faith. The other Party may
consider such pre-emptive right for at least [...***...] upon receipt of an offer before
losing its right of decision on the offer. Any times of negotiation between the Parties
shall toll this time limit.
	 
	B.8  	 	Compensation

 

			
	***	 	Confidential Treatment Requested

12

 

	 	 	Neither Party shall receive from the other Party compensation for
cooperating in the tasks contemplated by this Agreement. License fees
or any other forms of payment provided for separately under this
Agreement shall not be covered by this provision.
	 
	C.	 	PROJECT MARKETING
	 
	C.1  	 	Activities

	 	a)	 	Upon the commencement of first commercial production of Succinic Acid from any Plant
(located outside of the United States) constructed hereunder, or at such earlier time as
determined by the Steering Committee, the Steering Committee will assume the oversight and
coordination of proposal development and Project marketing activities for the Alliance
(herein “Project Marketing”). The marketing activities shall include, without
limitation, the following:

	 	(i)	 	determination as to which Projects it should market the Processes and to
whom it should do so; and
	 
	 	(ii)	 	[...***...];

	 	b)	 	The Parties will agree on forms of contract with mutually acceptable terms and
conditions for the provision of EPC services.
	 
	 	c)	 	The Parties shall work together in good faith to explore all related areas of
potential synergy that may enhance the ability of the Parties to win bids for and execute
Projects.

	C.2  	 	Business Development Projects

	 	a)	 	The Parties shall [...***...] on the development of Projects and
[...***...] with necessary sales and business development support, including, without
limitation, [...***...] with investor(s) for Projects, Plants (located outside of the United
States), process case analysis, budgetary and/or firm proposals and, to the extent
required, any Intellectual Property Rights necessary for the preparation of any Project
proposal.
	 
	 	b)	 	The Parties [...***...] related to Projects
and Plants [...***...] (for Plants outside of the United States).
	 
	 	c)	 	The Parties shall convene on a regular monthly basis (or other frequency as mutually
agreed to by the Parties) in person, by videoconference or telephonically to review the
new business opportunities, prioritize such opportunities, inform each other about the
current status of potential or existing Projects and other new Project opportunities that
have come to the knowledge of a Party, and to develop strategies for jointly developing
and acquiring such targeted opportunities.

 

			
	***	 	Confidential Treatment Requested

13

 

	 	d)	 	If either Party has identified a prospective Project,
[...***...]. A decision to pursue a Project must be [...***...].
	 
	 	e)	 	[...***...]
	 
	 	f)	 	If required by lenders or by applicable market conditions, Uhde may offer and perform
services to Myriant based on United States Dollars. However, should Uhde have parts of its
services performed based on Euro, to enable both Parties to take advantage of fluctuating
rates of exchange or to avoid their exposure during the validity period of any proposal,
Uhde shall fix the rate of exchange for the calculation of the respective Euro portion at
the rate valid as of the date of the proposal. Should there be an increase or decrease of
the exchange rate at the date of effectiveness of a contract based on such proposal, the
USD-Price shall be fixed in the contract by calculating this price according to the new
exchange rate quoted by the European Central Bank as official rate of exchange valid at
the date of such effectiveness.
	 
	 	g)	 	If an identified Project requires the Parties to enter into a joint venture with any
third party due to national or other legal restrictions, the Parties shall discuss and
agree on the appropriate structure on a case by case basis.

	C.3  	 	Proposal Development
	 
	 	 	The Parties recognize that during the Plant Proposal development process, Myriant may
require budgetary cost and performance information for its own evaluation of the
development of budgetary proposals for Myriant’s own investment purposes, an end customer
or a third party investor or lender for a Plant (located outside of the United States),
and/or for screening of process and/or supply concepts. Uhde agrees to provide at its own
cost the necessary sales and business development support for such budgetary estimates as
outlined below. Myriant will provide a functional specification for each opportunity,
which will include, at a minimum: product requirements, feed information, utility
availability, economic evaluation criteria, and preliminary site information. Uhde shall
provide the following deliverables for each budgetary proposal opportunity:

	 	•	 	Preliminary Process Flow Diagram (PFD) with its associated material balance;
	 
	 	•	 	Consumption/utility estimates; and
	 
	 	•	 	Budgetary cost estimates (+/-30%).

 

			
	***	 	Confidential Treatment Requested

14

 

	 	 	If Myriant asks for a firm proposal by Uhde, or if the Parties agree to jointly develop a
Project proposal for an end customer or investor or lender, they will agree on the scope
of work, the design basis of the Project, and the process concept as well as the
time-schedule for the proposal deliverables. In certain countries, Uhde’s project scope
of work will typically be an engineering/procurement approach (EP). In case of an EP
approach, if required for financing purposes, UCA is willing to act as a subcontractor to
the construction or prime contractor.
	 
	 	 	Myriant will provide a detailed specification for each Project proposal. This
specification will include, at a minimum:

	 	•	 	a process functional definition —including product requirements, feed
information, utility availability, emission limitations, and economic evaluation
criteria;
	 
	 	•	 	a technical specification — including equipment design criteria, instrumentation
requirements, and applicable codes and standards; and
	 
	 	•	 	an execution specification — including scope of work matrix, communication
requirements, schedule requirements, and site information.

	 	 	The schedule for the Uhde deliverables shall be agreed on by and between the Parties for
each Project proposal. The following Uhde deliverables are typical and depend on Uhde
Scope:

	 	a)	 	Technical Deliverables:

	 	•	 	Process flow diagram (PFD) with process description;
	 
	 	•	 	Heat and material balance;
	 
	 	•	 	Preliminary utility consumption (amounts and requirements); and
	 
	 	•	 	Preliminary time schedule.

	 	b)	 	Commercial Deliverables:

	 	•	 	Cost estimate (for Uhde scope only):

	 	•	 	Engineering services;
	 
	 	•	 	Equipment incl. transportation;
	 
	 	•	 	Bulk materials;
	 
	 	•	 	Site advisory services; and

	 	•	 	[...*****...].

	C.4  	 	Proposal Costs

 

			
	***	 	Confidential Treatment Requested

15

 

	 	 	Notwithstanding anything contained herein to the contrary, Uhde will be reimbursed by
Myriant for the reasonable costs incurred in the preparation of any proposals requested by
Myriant for any Project or Plant (located outside of the United States) in accordance with
Exhibit B attached hereto and made a part hereof; provided, however, that in no
event shall Myriant be required to pay both Uhde and UCA under the US Alliance Agreement
for the same items or service.
	 
	C.5  	 	[...***...].
	 
	C.6  	 	Process and Performance Guarantees
	 
	 	 	If an identified Project requires the provision of process and performance guarantees for
the Processes by Uhde, the Parties shall discuss and negotiate in good faith upon the
structure, conditions and form of such guarantees in consideration of the reliability of the
Processes at the time of such requirement. The Parties acknowledge and have discussed in
detail the provision that any process and/or performance guarantees by Uhde is explicitly
subject to the approval of Uhde’s Board of Directors. The Parties understand that, for
design-build projects, Myriant envisions using a traditional project finance structure
requiring process and performance guarantees with corresponding liquidated damage provisions
as noted in Item C.3 hereinabove.
	 
	D.	 	Miscellaneous
	 
	D.1  	 	Effective Date
	 
	 	 	This Agreement shall become effective upon execution by the last Party needing to sign
this Agreement.
	 
	D.2  	 	Representation
	 
	 	 	No Party shall have the right or obligation to represent the other
Party or to enter into any obligation of whatever kind for the other
Party. The Parties are independent contractors and nothing in this
Agreement shall be deemed to constitute, create, give effect to or
otherwise recognize a joint venture, partnership, or formal business
entity of any kind and the rights and obligations of the Parties shall
be limited to those expressly set forth herein.
	 
	D.3  	 	Confidentiality Agreement
	 
	 	 	The Parties shall treat all information exchanged under this Agreement as confidential
information in accordance with the Confidentiality Agreement signed between the Parties on
14 August 2009.

 

			
	***	 	Confidential Treatment Requested

16

 

	 	 	Neither Party shall publicly announce or disclose the existence of this Agreement or its
terms and conditions, or advertise or release any publicity regarding this association or
the Project without the prior consent of the other Party, such consent which shall not be
unreasonably withheld or delayed.
	 
	D.4  	 	Term
	 
	 	 	The Agreement shall be valid for a period of [...***...] from the time stated in Item D.1
of this Agreement (the “Term”) and shall, in consideration of any necessary
amendments according to Item C.6, continue thereafter if mutually extended by the Parties.
	 
	D.4.1  	 	Termination of Agreement
	 
	 	 	[...***...]. A Party that does not elect to renew this Agreement
shall notify the other of its intent not to renew this Agreement
before the expiry of the Term by providing the other Party 180 days
prior written notice to the other Party of its intention not to
renew.
	 
	D.4.2  	 	Termination with Immediate Effect
	 
	 	 	Either Party may terminate this Agreement — unless otherwise agreed upon between the
Parties — with immediate effect, if

	 	 a)	 	insolvency, bankruptcy, liquidation, receivership or dissolution of the
other Party occurs; or
	 
	 	 b)	 	either the Parties hereunder or UCA and Myriant, under the terms of the
U.S. Alliance Agreement, do not (i) [...***...] and (ii) [...***...], or
	 
	 	 c)	 	the other Party commits a material breach of any of its obligations under
the Agreement, which is not cured after notice, and a reasonable opportunity to cure
such breach.

	 	 	Except in the case of material breach, [...***...].
	 
	D.5  	 	Cooperation in the light of Antitrust Laws
	 
	 	 	Unless the Agreement is terminated in accordance with D.4.1 or D.4.2, the Parties shall
examine the Term and exclusivity provisions of Part A.1.1 and C.5 of this Agreement no
later than the sixth anniversary of the Effective Date in light of the then applicable
antitrust legislation. If required, the Parties shall make necessary revisions to the Term
and/or exclusivity provisions provided for in this Agreement.

 

			
	***	 	Confidential Treatment Requested

17

 

	D.6  	 	Waiver of Terms
	 
	 	 	This Agreement will not be modified except by an instrument in writing signed by or on
behalf of each Party. The failure of either Party to insist, in any one or more instances,
upon the performance of any of the terms, covenants or conditions of this Agreement or to
exercise any right hereunder, will not be construed as a waiver or relinquishment of the
future performance of any such terms, covenants or conditions or the future exercise of
such right, but the obligation of the other Party with respect to such future performance
will continue to be in full force and effect.
	 
	D.7  	 	Entire Agreement, Execution Costs, No Assignment
	 
	 	 	This Agreement and the Confidentiality Agreement referred to hereinafter in Item D.3
contains the entire agreement between the Parties with respect to the subject matter of
this Agreement and the transactions contemplated herein and it supersedes all prior
collateral communications, reports and understandings between the Parties with respect
thereto, including the Cooperation Agreement referred to hereinabove. It is understood
that this Agreement does not affect any other agreements between the Parties except those
specified herein. The Parties recognize and acknowledge that UCA and Myriant are
concurrently entering into a parallel agreement with similar terms and conditions for the
United States.
	 
	 	 	Each of the Parties shall bear its respective fees, costs, and expenses in connection with
the execution of this Agreement. Neither Party may assign this Agreement, in whole or in
part, or any rights hereunder without the prior written consent of the other Party, such
consent which will not be unreasonably withheld or delayed.
	 
	D.8  	 	Liability/ Indemnity
	 
	 	 	DURING THE EXECUTION OF THE RESEARCH AND DEVELOPMENT PROCESS; EACH PARTY SHALL USE ITS
CUSTOMARY CARE AND DILIGENCE IN ACCORDANCE WITH THE ACKNOWLEDGED SCIENTIFIC STANDARDS AND
TECHNOLOGY.
	 
	 	 	NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY FOR THE SUITABILITY, CORRECTNESS,
COMPLETENESS OR OTHER QUALITIES OF ANY OF THEIR RESEARCH AND DEVELOPMENT RESULTS AND
INFORMATION PROVIDED TO EACH OTHER UNDER THIS AGREEMENT. THE PARTIES SHALL EXPLICITLY NOT
BE LIABLE TO EACH OTHER FOR THE FAILURE TO ACHIEVE OF ANY OF THE GOALS OF THE ALLIANCE.
	 
	 	 	NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY BY WAY OF INDEMNITY OR BY REASONS OF TORT
(INCLUDING BUT NOT LIMITED TO NEGLIGENCE) OR OTHERWISE FOR ANY LOSS OF PROFIT, LOSS OF
USE, LOSS OF PRODUCTION, LOSS OF CONTRACT OR ANY

 

			
	***	 	Confidential Treatment Requested

18

 

	 	 	FINANCIAL OR ECONOMIC LOSS OR FOR ANY INDIRECT OR CONSEQUENTIAL DAMAGE OF WHATEVER CAUSE.
	 
	 	 	THE PARTIES’ RIGHTS AND REMEDIES AS STATED HEREIN ARE EXCLUSIVE AND IN LIEU OF ALL OTHER
REMEDIES WHETHER STATUTORY, EXPRESS OR IMPLIED AND ARE THE SOLE REMEDIES OF A PARTY FOR
THE FAILURE BY THE OTHER PARTY TO COMPLY WITH ITS OBLIGATIONS.
	 
	D.9  	 	Governing Law/Mediation/Arbitration
	 
	 	 	This Agreement shall be governed by and construed in accordance with the Substantive Laws
of Switzerland, without giving effect to their conflicts of law principles.
	 
	 	 	For any disputes between the Parties relating to Intellectual Property matters as provided
herein or that may otherwise arise between the Parties under this Agreement or in the
Alliance, the Parties may, in the first instance, without prejudice to any other
proceedings, seek to settle any dispute arising out
of or in connection with the present contract in accordance with the International Chamber
of Commerce (the “ICC”) ADR Rules (the “ICC ADR Rules”). The Parties shall jointly
appoint a sole intellectual property mediator who is a nationally recognized expert in
intellectual property matters to adjudicate such disputes. Failing the joint appointment,
the mediator shall be chosen by the ICC. Each Party may be represented by counsel at the
mediation, but each Party must attend through an officer having authority to agree to a
settlement at the mediation. The mediation session shall occur in Zurich, Switzerland, and
shall extend no longer than a single day. Statements or offers made at the mediation
session shall not be admissible in any later arbitration hearing. Each Party shall bear
its own fees and expenses, including payments to its own chosen experts, and an equal
share of the expenses and fees of the mediator and the ICC. The Parties, their
representatives, other participants and the mediator shall hold the existence, content and
result of the mediation in confidence.
	 
	 	 	Any disputes arising out of or in connection with this Agreement shall exclusively and
finally be settled under the Rules of Arbitration (the “ICC Rules”) of the
International Chamber of Commerce (the “ICC”) The arbitral tribunal determining
any dispute shall be comprised of three arbitrators. Each Party to a dispute shall
designate one arbitrator. If a Party fails to designate an arbitrator within a reasonable
period, the ICC shall designate an arbitrator for such Party. The two arbitrators
designated by the Parties to a dispute (or, if applicable, the ICC) shall designate a
third arbitrator. In the event that the two arbitrators designated by the Parties to a
dispute (or, if applicable, the ICC) are unable to agree upon a third arbitrator within a
reasonable period, the third arbitrator shall be selected in accordance with the ICC Rules
by the ICC. The language of the arbitration shall be in English, and the place of the
arbitration of any dispute shall be held in Zurich, Switzerland or any other venue as
agreed upon by the Parties to such a dispute. If neither the Parties nor the arbitral
tribunal can agree upon procedures, the arbitration shall be

 

			
	***	 	Confidential Treatment Requested

19

 

	 	 	conducted in accordance with the ICC’s procedures. The hearings and taking of evidence of
any dispute may be conducted at any locations that will, in the judgment of the arbitral
tribunal, result in a speedy, efficient and just resolution of such dispute. The Parties
to any dispute shall use their reasonable best efforts to cooperate with each other and
the arbitral tribunal in order to obtain a resolution as quickly as possible, including by
adopting the ICC’s “fast-track” procedure (as provided for in Article 32(1) of the ICC
Rules) if appropriate.
	 
	 	 	Notwithstanding the above, each Party acknowledges that its breach of the Agreement may
cause irreparable damage to the other Party and hereby agrees that without prejudice to
the before mentioned the other Party shall be entitled to seek injunctive relief under
this Agreement for such breach.
	 
	D.10  	 	Amendments
	 
	 	 	This Agreement may not be changed or amended orally, but only in writing signed by the
Parties hereto. The writing must refer to this Agreement and must expressly state that it
is an amendment hereof.
	 
	D.11  	 	Severability
	 
	 	 	The circumstance that any provision or part of it of this Agreement is held
to be void, illegal, unenforceable or contrary to law or public policy shall
not affect the validity of the remaining provision(s) of this Agreement. The
invalid, illegal or unenforceable provision or part of it will be replaced by
an admissible one, aiming at the same economic and legal results.
	 
	D.12  	 	 Force Majeure
	 
	 	 	No Party shall be liable, in respect to any delay in completion of work
hereunder or of the non-performance of any term or condition of this Alliance
directly or indirectly resulting from delays by Acts of God; acts of the
public enemy; strikes; lockouts; epidemic and riots; power failure; water
shortage or adverse weather conditions; or other causes beyond the control of
the Parties. In the event of any of the foregoing, the time for performance
shall be equitably and immediately adjusted, and in no event shall any Party
be liable for any consequential or incidental damages from its performance or
non-performance of any term or condition of this Alliance. The Parties shall
resume the completion of work under this Alliance as soon as possible
subsequent to any delay due to force majeure.
	 
	D.13  	 	Further Assurances
	 
	 	 	The Parties agree and acknowledge that this Agreement grants certain rights
and responsibilities to each other and that it also provides certain
“framework” arrangements of a prospective nature between the Parties. In
that regard, the Parties may elect to enter into such other agreements as may
be necessary to reflect the intent of the Parties on a going—forward basis.

 

			
	***	 	Confidential Treatment Requested

20

 

	 	 	 	 	 	 	 	 	 	 	 

	Myriant Technologies LLC	 	 	 	Uhde GmbH
	 
	 	 	 	 	 	 	 	 	 	 
	Place, Date: Quincy, 6 October 2009	 	 	 	Place, Date: Dortmund, 6 October 2009
	 
	 	 	 	 	 	 	 	 	 	 
	Signature: 

	/s/ Samuel G. McConnell
 

	 	 	 	Signature: 
	/s/ Joachim Schultze
 

	 	 
	

	Name: 	Samuel G. McConnell
	 	 	 	
	Name: 	Joachim Schultze	 	 
	

	Position: 	Senior Vice President
	 	 	 	
	Position: 	Head of Uhde Biotechnology	 	 

 

			
	***	 	Confidential Treatment Requested

21

 

Annex 1-Definitions

	 	 	 

	Affiliate(s)

	 	An Affiliate of a Party is a person or entity that directly, or indirectly through
one or more intermediaries, controls, or is controlled by, or is under common control
with, such Party.
	 
	 	 
	Agreement

	 	means this Global Alliance Agreement in its version as signed by both Parties and of
which each Party shall hold one original copy.
	 
	 	 
	Alliance

	 	means the relationship between the Parties contemplated by this Agreement.
	 
	 	 
	EP

	 	means the engineering and procurement functions for the Plants (located outside of
the United States).
	 
	 	 
	EPC

	 	means the engineering, procurement and construction functions for the Plants (located
outside of the United States).
	 
	 	 
	Field

	 	means the field of Succinic Acid.
	 
	 	 
	Intellectual Property 

Rights

	 	means any and all Intellectual Property Rights in, to, or arising out of any (i) Patents; (ii) trade secrets; (iii) know-how; (iv) copyrights,
copyright registrations, or any national or regional application therefor, in any
territory, or any other right corresponding thereto throughout the world; or (v) any other
intellectual property or proprietary right anywhere in the world.
	 
	 	 
	Joint Working Results

	 	means (i) improvements to the Myriant Process made by Uhde or
jointly by Uhde and Myriant, (ii) improvements to the Uhde Process made by Myriant or
jointly by Uhde and Myriant, (iii) new processes jointly developed by the two Parties, or
(iv) new processes developed solely or substantially by one of the Parties with reference
to the other Party’s intellectual property, as such improvements or new processes are
developed within the scope of the collaboration as defined herein, together and/or
singularly, as the context may indicate.
	 
	 	 
	Myriant

	 	means Myriant Technologies LLC, a limited liability company duly organised under the
laws of Delaware with its principal office at 1 Pinehill Drive, Batterymarch Park II,
Suite 301, Quincy, MA 02169, USA.
	 
	 	 
	Myriant Improvement

	 	means any improvement to the Myriant Process solely developed by Myriant
without reference to any Uhde or Uhde intellectual property.

 

			
	***	 	Confidential Treatment Requested

22

 

	 	 	 

	Myriant Process

	 	means a proprietary fermentation technology developed by Myriant [...***...].
	 
	 	 
	Patent

	 	means any and all rights under any of the following, whether existing now or in the
future: (i) all national, regional and international patents and patent applications,
including provisional patent applications, utility model, design registration, certificate
of invention, patent of addition or substitution, or other governmental grant for the
protection of inventions or industrial designs anywhere in the world, including any
reissue, renewal, re-examination or extension thereof; and (ii) any application for any of
the foregoing, including any international, provisional, divisional, continuation,
continuation-in-part, or continued prosecution application.
	 
	 	 
	Pilot Plant

	 	means the Fermic Sa de CV’s tolling facility in Mexico City, Mexico configured
and contracted by Myriant for the production of Succinic Acid at a semi-industrial scale.
	 
	 	 
	Plant(s)

	 	means commercial scale Succinic Acid production facility(ies) located outside the
United States utilizing the Processes.
	 
	 	 
	Prior IP Record

	 	means any Patent application; document substantiating the existence of a
trade secret, proprietary technology or know-how; copyrighted work; copyright
registration; engineering lab book, record or drawing, or any national or regional
application therefor.
	 
	 	 
	Project

	 	means that series of activities and tasks in support of the financing, siting, design,
engineering, construction procurement and/or operation of commercial scale Plants located
outside of the United States utilizing the Processes.
	 
	 	 
	Processes

	 	means the Myriant Process together with the Uhde Process when the context so
indicates.
	 
	 	 
	Steering Committee

	 	means the Alliance steering committee comprised of four (4) members with
equal representation by Myriant and Uhde.
	 
	 	 
	UCA

	 	means Uhde Corporation of America, a company duly organised under the laws of
Delaware with its principal office at 1370 Washington Pike, Bridgeville, PA 15017, USA and
an Affiliate of Uhde (defined hereunder).
	 
	 	 
	UCA-Myriant

	 	means the contemplated Succinic Acid production facility

 

			
	***	 	Confidential Treatment Requested

23

 

	 	 	 

	Demonstration Plant

	 	with an annual output of 30 million pounds to be located in the United
States.
	 
	 	 
	Uhde

	 	means Uhde GmbH, a company duly organised under the laws of the Federal Republic of
Germany with its principal office at Friedrich-Uhde-Str. 15, 44141 Dortmund, Germany.
	 
	 	 
	Uhde Improvement

	 	means any improvement to the Uhde Process solely developed by Uhde
without reference to any Myriant intellectual property.
	 
	 	 
	Uhde Process

	 	means a proprietary separation technology developed by Uhde [...***...]
	 
	 	 
	Joint Working Results

	 	means (i) improvements to the Myriant Process made by Uhde or by
Myriant and Uhde jointly, (ii) improvements to the Uhde Process made by Myriant or by
Myriant and Uhde jointly, (iii) new processes jointly developed by the two Parties, or
(iv) new processes developed solely or substantially by one of the Parties but with
reference to the other Party’s intellectual property, as such improvements or new
processes are developed within the scope of the collaboration as defined herein, together
and/or singularly, as the context may indicate.

 

			
	***	 	Confidential Treatment Requested

24

 

EXHIBIT A — Uhde Process License Fee Structure

License Fee in EUR:

	 	•	 	for capacities below [...***...] MT/year: [...***...]
	 
	 	•	 	for capacities between [...***...] and [...***...] MT/year:

	 	•	 	[...***...]
	 
	 	•	 	[...***...]

	 	•	 	for capacities above [...***...] MT/year: to be discussed.

 

			
	***	 	Confidential Treatment Requested

25

 

EXHIBIT B — Engineering and Plant Proposal Fees

For Engineering Services including Plant Proposal services provided by Uhde under this
Agreement, Myriant shall pay to Uhde the following hourly rates:

	a)	 	for home office engineering performed by Uhde through Uhde in Germany:
[...***...];
	 
	b)	 	for home office engineering performed by Uhde through Uhde Engineering de
Mexico S.A. de C.V.: [...***...]; and
	 
	c)	 	for assignment of personnel out of home office, the Parties shall agree on
daily rates including incidental cost in due course.

The rates indicated under a) through c) above are based on 40 working hours/week (Mon-Fri)
and shall be valid until 30.09.2010. Thereafter, the rates shall be escalated on the first
date of each subsequent year in accordance with the increase of salaries and incidental
salary expenses as substantiated by Uhde.

The above rates may differentiate between different categories and different Uhde offices.

The Parties shall mutually agree at agreed intervals on which rates shall be applied to
which work packages.

Additional cost, e.g. travel and accommodation cost in case of business trips, etc., shall
be reimbursed in addition to the above rates.

The above mentioned rates shall be invoiced by Uhde on a monthly basis and shall be
payable within 30 days after receipt of invoice.

Compensation for Supplies

[...***...] shall be mutually agreed prior to the start of engineering of any
Plant (located outside the United States) constructed by the Parties pursuant to this
Agreement.

 

			
	***	 	Confidential Treatment Requested

26

 

EXHIBIT C — [...***...]

[...***...]

 

			
	***	 	Confidential Treatment Requested

27

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}]]